Gene/Region,Disease Label,SOP,GRCh38,Protein Name
KRAS,cardiofaciocutaneous syndrome,SOP5,chr12:25205246-25250929,GTPase KRas
KRAS,cardiofaciocutaneous syndrome,SOP5,chr12:25205246-25250929,GTPase KRas
KRAS,cardiofaciocutaneous syndrome,SOP5,chr12:25205246-25250929,GTPase KRas
KRAS,cardiofaciocutaneous syndrome,SOP5,chr12:25205246-25250929,GTPase KRas
KRAS,Costello syndrome,SOP5,chr12:25205246-25250929,GTPase KRas
KRAS,Costello syndrome,SOP5,chr12:25205246-25250929,GTPase KRas
KRAS,Costello syndrome,SOP5,chr12:25205246-25250929,GTPase KRas
KRAS,Costello syndrome,SOP5,chr12:25205246-25250929,GTPase KRas
CEP78,cone-rod dystrophy and hearing loss,SOP4,chr9:78236075-78279690,Centrosomal protein of 78 kDa
CEP78,cone-rod dystrophy and hearing loss,SOP4,chr9:78236075-78279690,Centrosomal protein of 78 kDa
TP73,"ciliary dyskinesia, primary, 47, and lissencephaly",SOP10,chr1:3652516-3736201,Tumor protein p73
ALG2,ALG2-congenital disorder of glycosylation,SOP9,chr9:99216425-99221942,Programmed cell death protein 6
ALG2,ALG2-congenital disorder of glycosylation,SOP9,chr9:99216425-99221942,Programmed cell death protein 6
TRDN,long QT syndrome,SOP7,chr6:123216339-123636950,Triadin
TRDN,long QT syndrome,SOP7,chr6:123216339-123636950,Triadin
TRDN,long QT syndrome,SOP7,chr6:123216339-123636950,Triadin
KCNQ1,short QT syndrome,SOP7,chr11:2445008-2849105,Potassium voltage-gated channel subfamily KQT member 1
KCNQ1,short QT syndrome,SOP7,chr11:2445008-2849105,Potassium voltage-gated channel subfamily KQT member 1
KCNQ1,short QT syndrome,SOP7,chr11:2445008-2849105,Potassium voltage-gated channel subfamily KQT member 1
KCNQ1,short QT syndrome,SOP7,chr11:2445008-2849105,Potassium voltage-gated channel subfamily KQT member 1
KCNQ1,short QT syndrome,SOP7,chr11:2445008-2849105,Potassium voltage-gated channel subfamily KQT member 1
KCNQ1,short QT syndrome,SOP7,chr11:2445008-2849105,Potassium voltage-gated channel subfamily KQT member 1
KCNQ1,hypertrophic cardiomyopathy,SOP8,chr11:2445008-2849105,Potassium voltage-gated channel subfamily KQT member 1
KCNQ1,hypertrophic cardiomyopathy,SOP8,chr11:2445008-2849105,Potassium voltage-gated channel subfamily KQT member 1
KCNQ1,hypertrophic cardiomyopathy,SOP8,chr11:2445008-2849105,Potassium voltage-gated channel subfamily KQT member 1
KCNQ1,hypertrophic cardiomyopathy,SOP8,chr11:2445008-2849105,Potassium voltage-gated channel subfamily KQT member 1
KCNQ1,hypertrophic cardiomyopathy,SOP8,chr11:2445008-2849105,Potassium voltage-gated channel subfamily KQT member 1
KCNQ1,hypertrophic cardiomyopathy,SOP8,chr11:2445008-2849105,Potassium voltage-gated channel subfamily KQT member 1
GCSH,glycine encephalopathy,SOP9,chr16:81081945-81096395,Glycine cleavage system H protein
ACOX1,Mitchell syndrome,SOP9,chr17:75941507-75979166,Peroxisomal acyl-coenzyme A oxidase 1
ACOX1,Mitchell syndrome,SOP9,chr17:75941507-75979166,Peroxisomal acyl-coenzyme A oxidase 1
SETD2,SETD2-related microcephaly-severe intellectual disability-multiple congenital anomalies syndrome,SOP9,chr3:47016436-47164840,Histone-lysine N-methyltransferase SETD2
SETD2,SETD2-related microcephaly-severe intellectual disability-multiple congenital anomalies syndrome,SOP9,chr3:47016436-47164840,Histone-lysine N-methyltransferase SETD2
SETD2,SETD2-related microcephaly-severe intellectual disability-multiple congenital anomalies syndrome,SOP9,chr3:47016436-47164840,Histone-lysine N-methyltransferase SETD2
SETD2,SETD2-related neurodevelopmental disorder without or with macrocephaly/overgrowth,SOP9,chr3:47016436-47164840,Histone-lysine N-methyltransferase SETD2
SETD2,SETD2-related neurodevelopmental disorder without or with macrocephaly/overgrowth,SOP9,chr3:47016436-47164840,Histone-lysine N-methyltransferase SETD2
SETD2,SETD2-related neurodevelopmental disorder without or with macrocephaly/overgrowth,SOP9,chr3:47016436-47164840,Histone-lysine N-methyltransferase SETD2
ATF6,achromatopsia,SOP4,chr1:161766320-161964070,Cyclic AMP-dependent transcription factor ATF-6 alpha
ATF6,achromatopsia,SOP4,chr1:161766320-161964070,Cyclic AMP-dependent transcription factor ATF-6 alpha
ATF6,achromatopsia,SOP4,chr1:161766320-161964070,Cyclic AMP-dependent transcription factor ATF-6 alpha
SLC4A10,complex neurodevelopmental disorder,SOP11,chr2:161624416-161985270,Sodium-driven chloride bicarbonate exchanger
RPE65,RPE65-related dominant retinopathy,SOP8,chr1:68428822-68449954,Retinoid isomerohydrolase
RPE65,RPE65-related dominant retinopathy,SOP8,chr1:68428822-68449954,Retinoid isomerohydrolase
RPE65,RPE65-related dominant retinopathy,SOP8,chr1:68428822-68449954,Retinoid isomerohydrolase
RPE65,RPE65-related dominant retinopathy,SOP8,chr1:68428822-68449954,Retinoid isomerohydrolase
RPE65,RPE65-related dominant retinopathy,SOP8,chr1:68428822-68449954,Retinoid isomerohydrolase
RPE65,RPE65-related dominant retinopathy,SOP8,chr1:68428822-68449954,Retinoid isomerohydrolase
RPE65,RPE65-related recessive retinopathy,SOP8,chr1:68428822-68449954,Retinoid isomerohydrolase
RPE65,RPE65-related recessive retinopathy,SOP8,chr1:68428822-68449954,Retinoid isomerohydrolase
RPE65,RPE65-related recessive retinopathy,SOP8,chr1:68428822-68449954,Retinoid isomerohydrolase
RPE65,RPE65-related recessive retinopathy,SOP8,chr1:68428822-68449954,Retinoid isomerohydrolase
RPE65,RPE65-related recessive retinopathy,SOP8,chr1:68428822-68449954,Retinoid isomerohydrolase
RPE65,RPE65-related recessive retinopathy,SOP8,chr1:68428822-68449954,Retinoid isomerohydrolase
MYLK,familial thoracic aortic aneurysm and aortic dissection,SOP4,chr3:123610049-123884332,Myosin light chain kinase
MYLK,familial thoracic aortic aneurysm and aortic dissection,SOP4,chr3:123610049-123884332,Myosin light chain kinase
SCN1A,developmental and epileptic encephalopathy,SOP7,chr2:165984641-166149161,Sodium channel protein type 1 subunit alpha
SCN1A,developmental and epileptic encephalopathy,SOP7,chr2:165984641-166149161,Sodium channel protein type 1 subunit alpha
SCN1A,developmental and epileptic encephalopathy,SOP7,chr2:165984641-166149161,Sodium channel protein type 1 subunit alpha
SCN1A,developmental and epileptic encephalopathy,SOP7,chr2:165984641-166149161,Sodium channel protein type 1 subunit alpha
SCN1A,developmental and epileptic encephalopathy,SOP7,chr2:165984641-166149161,Sodium channel protein type 1 subunit alpha
SCN1A,developmental and epileptic encephalopathy,SOP7,chr2:165984641-166149161,Sodium channel protein type 1 subunit alpha
SCN1A,familial hemiplegic migraine,SOP7,chr2:165984641-166149161,Sodium channel protein type 1 subunit alpha
SCN1A,familial hemiplegic migraine,SOP7,chr2:165984641-166149161,Sodium channel protein type 1 subunit alpha
SCN1A,familial hemiplegic migraine,SOP7,chr2:165984641-166149161,Sodium channel protein type 1 subunit alpha
SCN1A,familial hemiplegic migraine,SOP7,chr2:165984641-166149161,Sodium channel protein type 1 subunit alpha
SCN1A,familial hemiplegic migraine,SOP7,chr2:165984641-166149161,Sodium channel protein type 1 subunit alpha
SCN1A,familial hemiplegic migraine,SOP7,chr2:165984641-166149161,Sodium channel protein type 1 subunit alpha
SCN1A,generalized epilepsy with febrile seizures plus,SOP6,chr2:165984641-166149161,Sodium channel protein type 1 subunit alpha
SCN1A,generalized epilepsy with febrile seizures plus,SOP6,chr2:165984641-166149161,Sodium channel protein type 1 subunit alpha
SCN1A,generalized epilepsy with febrile seizures plus,SOP6,chr2:165984641-166149161,Sodium channel protein type 1 subunit alpha
SCN1A,generalized epilepsy with febrile seizures plus,SOP6,chr2:165984641-166149161,Sodium channel protein type 1 subunit alpha
SCN1A,generalized epilepsy with febrile seizures plus,SOP6,chr2:165984641-166149161,Sodium channel protein type 1 subunit alpha
SCN1A,generalized epilepsy with febrile seizures plus,SOP6,chr2:165984641-166149161,Sodium channel protein type 1 subunit alpha
RINT1,hereditary breast carcinoma,SOP9,chr7:105532201-105567677,RAD50-interacting protein 1
RINT1,hereditary breast carcinoma,SOP9,chr7:105532201-105567677,RAD50-interacting protein 1
RINT1,familial ovarian cancer,SOP4,chr7:105532201-105567677,RAD50-interacting protein 1
RINT1,familial ovarian cancer,SOP4,chr7:105532201-105567677,RAD50-interacting protein 1
RYR2,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr1:237042184-237833988,Ryanodine receptor 2
RYR2,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr1:237042184-237833988,Ryanodine receptor 2
RYR2,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr1:237042184-237833988,Ryanodine receptor 2
RYR2,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr1:237042184-237833988,Ryanodine receptor 2
RYR2,hypertrophic cardiomyopathy,SOP9,chr1:237042184-237833988,Ryanodine receptor 2
RYR2,hypertrophic cardiomyopathy,SOP9,chr1:237042184-237833988,Ryanodine receptor 2
RYR2,hypertrophic cardiomyopathy,SOP9,chr1:237042184-237833988,Ryanodine receptor 2
RYR2,hypertrophic cardiomyopathy,SOP9,chr1:237042184-237833988,Ryanodine receptor 2
MUTYH,hereditary breast carcinoma,SOP9,chr1:45329242-45340440,Adenine DNA glycosylase
MUTYH,hereditary breast carcinoma,SOP9,chr1:45329242-45340440,Adenine DNA glycosylase
MUTYH,hereditary breast carcinoma,SOP9,chr1:45329242-45340440,Adenine DNA glycosylase
MUTYH,hereditary breast carcinoma,SOP9,chr1:45329242-45340440,Adenine DNA glycosylase
MUTYH,colorectal cancer,SOP9,chr1:45329242-45340440,Adenine DNA glycosylase
MUTYH,colorectal cancer,SOP9,chr1:45329242-45340440,Adenine DNA glycosylase
MUTYH,colorectal cancer,SOP9,chr1:45329242-45340440,Adenine DNA glycosylase
MUTYH,colorectal cancer,SOP9,chr1:45329242-45340440,Adenine DNA glycosylase
MUTYH,hereditary breast carcinoma,SOP9,chr1:45329242-45340440,Adenine DNA glycosylase
MUTYH,hereditary breast carcinoma,SOP9,chr1:45329242-45340440,Adenine DNA glycosylase
MUTYH,hereditary breast carcinoma,SOP9,chr1:45329242-45340440,Adenine DNA glycosylase
MUTYH,hereditary breast carcinoma,SOP9,chr1:45329242-45340440,Adenine DNA glycosylase
MUTYH,familial ovarian cancer,SOP9,chr1:45329242-45340440,Adenine DNA glycosylase
MUTYH,familial ovarian cancer,SOP9,chr1:45329242-45340440,Adenine DNA glycosylase
MUTYH,familial ovarian cancer,SOP9,chr1:45329242-45340440,Adenine DNA glycosylase
MUTYH,familial ovarian cancer,SOP9,chr1:45329242-45340440,Adenine DNA glycosylase
MUTYH,familial ovarian cancer,SOP9,chr1:45329242-45340440,Adenine DNA glycosylase
MUTYH,familial ovarian cancer,SOP9,chr1:45329242-45340440,Adenine DNA glycosylase
MUTYH,familial ovarian cancer,SOP9,chr1:45329242-45340440,Adenine DNA glycosylase
MUTYH,familial ovarian cancer,SOP9,chr1:45329242-45340440,Adenine DNA glycosylase
EPCAM,hereditary breast carcinoma,SOP9,chr2:47369311-47387020,Epithelial cell adhesion molecule
EPCAM,hereditary breast carcinoma,SOP9,chr2:47369311-47387020,Epithelial cell adhesion molecule
EPCAM,hereditary breast carcinoma,SOP9,chr2:47369311-47387020,Epithelial cell adhesion molecule
EPCAM,hereditary breast carcinoma,SOP9,chr2:47369311-47387020,Epithelial cell adhesion molecule
GEN1,hereditary breast carcinoma,SOP9,chr2:17753278-17788946,Flap endonuclease GEN homolog 1
GEN1,hereditary breast carcinoma,SOP9,chr2:17753278-17788946,Flap endonuclease GEN homolog 1
GEN1,familial ovarian cancer,SOP4,chr2:17753278-17788946,Flap endonuclease GEN homolog 1
GEN1,familial ovarian cancer,SOP4,chr2:17753278-17788946,Flap endonuclease GEN homolog 1
GJB6,nonsyndromic genetic hearing loss,SOP5,chr13:20221962-20232319,Gap junction beta-6 protein
GJB6,nonsyndromic genetic hearing loss,SOP5,chr13:20221962-20232319,Gap junction beta-6 protein
CNTNAP5,complex neurodevelopmental disorder,SOP10,chr2:124025287-124921219,Contactin-associated protein-like 5
SRPX2,epilepsy,SOP9,chrX:100644199-100675788,Sushi repeat-containing protein SRPX2
CHRNA7,epilepsy,SOP9,chr15:32030483-32173018,Neuronal acetylcholine receptor subunit alpha-7
MLH1,hereditary breast carcinoma,SOP10,chr3:36993466-37050846,DNA mismatch repair protein Mlh1
MLH1,hereditary breast carcinoma,SOP10,chr3:36993466-37050846,DNA mismatch repair protein Mlh1
MLH1,hereditary breast carcinoma,SOP10,chr3:36993466-37050846,DNA mismatch repair protein Mlh1
MLH1,hereditary breast carcinoma,SOP10,chr3:36993466-37050846,DNA mismatch repair protein Mlh1
MLH1,hereditary breast carcinoma,SOP10,chr3:36993466-37050846,DNA mismatch repair protein Mlh1
NBN,hereditary breast carcinoma,SOP9,chr8:89933331-89984667,Nibrin
NBN,hereditary breast carcinoma,SOP9,chr8:89933331-89984667,Nibrin
CHEK2,familial ovarian cancer,SOP10,chr22:28687743-28741834,Serine/threonine-protein kinase Chk2
CHEK2,familial ovarian cancer,SOP10,chr22:28687743-28741834,Serine/threonine-protein kinase Chk2
CHEK2,familial ovarian cancer,SOP10,chr22:28687743-28741834,Serine/threonine-protein kinase Chk2
CHEK2,familial ovarian cancer,SOP10,chr22:28687743-28741834,Serine/threonine-protein kinase Chk2
CHEK2,hereditary nonpolyposis colon cancer,SOP4,chr22:28687743-28741834,Serine/threonine-protein kinase Chk2
CHEK2,hereditary nonpolyposis colon cancer,SOP4,chr22:28687743-28741834,Serine/threonine-protein kinase Chk2
CHEK2,hereditary nonpolyposis colon cancer,SOP4,chr22:28687743-28741834,Serine/threonine-protein kinase Chk2
CHEK2,hereditary nonpolyposis colon cancer,SOP4,chr22:28687743-28741834,Serine/threonine-protein kinase Chk2
BRIP1,hereditary breast carcinoma,SOP9,chr17:61679139-61863528,Fanconi anemia group J protein
BRIP1,hereditary breast carcinoma,SOP9,chr17:61679139-61863528,Fanconi anemia group J protein
BRIP1,hereditary breast carcinoma,SOP9,chr17:61679139-61863528,Fanconi anemia group J protein
BRIP1,hereditary breast carcinoma,SOP9,chr17:61679139-61863528,Fanconi anemia group J protein
BRIP1,hereditary breast carcinoma,SOP9,chr17:61679139-61863528,Fanconi anemia group J protein
CPA6,epilepsy,SOP8,chr8:67422038-67746360,Carboxypeptidase A6
CPA6,epilepsy,SOP8,chr8:67422038-67746360,Carboxypeptidase A6
MRE11,familial ovarian cancer,SOP10,chr11:94415570-94512412,Double-strand break repair protein MRE11
MRE11,familial ovarian cancer,SOP10,chr11:94415570-94512412,Double-strand break repair protein MRE11
MRE11,hereditary breast carcinoma,SOP9,chr11:94415570-94512412,Double-strand break repair protein MRE11
MRE11,hereditary breast carcinoma,SOP9,chr11:94415570-94512412,Double-strand break repair protein MRE11
MSH2,hereditary breast carcinoma,SOP9,chr2:47403067-47709830,DNA mismatch repair protein Msh2
MSH2,hereditary breast carcinoma,SOP9,chr2:47403067-47709830,DNA mismatch repair protein Msh2
MSH2,hereditary breast carcinoma,SOP9,chr2:47403067-47709830,DNA mismatch repair protein Msh2
MSH2,hereditary breast carcinoma,SOP9,chr2:47403067-47709830,DNA mismatch repair protein Msh2
MSH2,hereditary breast carcinoma,SOP9,chr2:47403067-47709830,DNA mismatch repair protein Msh2
MSH2,hereditary breast carcinoma,SOP9,chr2:47403067-47709830,DNA mismatch repair protein Msh2
PIK3CA,hereditary breast carcinoma,SOP9,chr3:179148126-179240093,Phosphatidylinositol 4
PIK3CA,hereditary breast carcinoma,SOP9,chr3:179148126-179240093,Phosphatidylinositol 4
PIK3CA,hereditary breast carcinoma,SOP9,chr3:179148126-179240093,Phosphatidylinositol 4
PIK3CA,familial ovarian cancer,SOP4,chr3:179148126-179240093,Phosphatidylinositol 4
PIK3CA,familial ovarian cancer,SOP4,chr3:179148126-179240093,Phosphatidylinositol 4
PIK3CA,familial ovarian cancer,SOP4,chr3:179148126-179240093,Phosphatidylinositol 4
MYL2,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr12:110910845-110921449,Myosin regulatory light chain 2
MYL2,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr12:110910845-110921449,Myosin regulatory light chain 2
MYL2,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr12:110910845-110921449,Myosin regulatory light chain 2
MYL2,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr12:110910845-110921449,Myosin regulatory light chain 2
MYL2,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr12:110910845-110921449,Myosin regulatory light chain 2
MYL2,dilated cardiomyopathy,SOP7,chr12:110910845-110921449,Myosin regulatory light chain 2
MYL2,dilated cardiomyopathy,SOP7,chr12:110910845-110921449,Myosin regulatory light chain 2
MYL2,dilated cardiomyopathy,SOP7,chr12:110910845-110921449,Myosin regulatory light chain 2
MYL2,dilated cardiomyopathy,SOP7,chr12:110910845-110921449,Myosin regulatory light chain 2
MYL2,dilated cardiomyopathy,SOP7,chr12:110910845-110921449,Myosin regulatory light chain 2
CRKL,congenital heart disease,SOP9,chr22:20917407-20953747,Crk-like protein
TNNT2,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr1:201359014-201377680,Troponin T
TNNT2,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr1:201359014-201377680,Troponin T
TNNT2,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr1:201359014-201377680,Troponin T
TNNT2,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr1:201359014-201377680,Troponin T
TNNT2,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr1:201359014-201377680,Troponin T
TNNT2,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr1:201359014-201377680,Troponin T
TNNI3,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr19:55151767-55157732,Troponin I
TNNI3,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr19:55151767-55157732,Troponin I
TNNI3,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr19:55151767-55157732,Troponin I
TNNI3,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr19:55151767-55157732,Troponin I
TNNI3,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr19:55151767-55157732,Troponin I
TNNI3,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr19:55151767-55157732,Troponin I
TNNI3,dilated cardiomyopathy,SOP7,chr19:55151767-55157732,Troponin I
TNNI3,dilated cardiomyopathy,SOP7,chr19:55151767-55157732,Troponin I
TNNI3,dilated cardiomyopathy,SOP7,chr19:55151767-55157732,Troponin I
TNNI3,dilated cardiomyopathy,SOP7,chr19:55151767-55157732,Troponin I
TNNI3,dilated cardiomyopathy,SOP7,chr19:55151767-55157732,Troponin I
TNNI3,dilated cardiomyopathy,SOP7,chr19:55151767-55157732,Troponin I
SDHC,mitochondrial disease,SOP8,chr1:161314381-161363206,Succinate dehydrogenase cytochrome b560 subunit
SDHC,mitochondrial disease,SOP8,chr1:161314381-161363206,Succinate dehydrogenase cytochrome b560 subunit
SDHC,mitochondrial disease,SOP8,chr1:161314381-161363206,Succinate dehydrogenase cytochrome b560 subunit
SDHC,mitochondrial disease,SOP8,chr1:161314381-161363206,Succinate dehydrogenase cytochrome b560 subunit
SDHC,hereditary pheochromocytoma-paraganglioma,SOP8,chr1:161314381-161363206,Succinate dehydrogenase cytochrome b560 subunit
SDHC,hereditary pheochromocytoma-paraganglioma,SOP8,chr1:161314381-161363206,Succinate dehydrogenase cytochrome b560 subunit
SDHC,hereditary pheochromocytoma-paraganglioma,SOP8,chr1:161314381-161363206,Succinate dehydrogenase cytochrome b560 subunit
SDHC,hereditary pheochromocytoma-paraganglioma,SOP8,chr1:161314381-161363206,Succinate dehydrogenase cytochrome b560 subunit
CHEK1,familial ovarian cancer,SOP4,chr11:125625136-125681124,Serine/threonine-protein kinase Chk1
CHEK1,familial ovarian cancer,SOP4,chr11:125625136-125681124,Serine/threonine-protein kinase Chk1
CHEK1,hereditary breast carcinoma,SOP4,chr11:125625136-125681124,Serine/threonine-protein kinase Chk1
CHEK1,hereditary breast carcinoma,SOP4,chr11:125625136-125681124,Serine/threonine-protein kinase Chk1
ACTC1,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr15:34790230-34795549,Actin
ACTC1,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr15:34790230-34795549,Actin
ACTC1,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr15:34790230-34795549,Actin
ACTC1,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr15:34790230-34795549,Actin
ACTC1,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr15:34790230-34795549,Actin
ACTC1,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr15:34790230-34795549,Actin
ACTC1,dilated cardiomyopathy,SOP7,chr15:34790230-34795549,Actin
ACTC1,dilated cardiomyopathy,SOP7,chr15:34790230-34795549,Actin
ACTC1,dilated cardiomyopathy,SOP7,chr15:34790230-34795549,Actin
ACTC1,dilated cardiomyopathy,SOP7,chr15:34790230-34795549,Actin
ACTC1,dilated cardiomyopathy,SOP7,chr15:34790230-34795549,Actin
ACTC1,dilated cardiomyopathy,SOP7,chr15:34790230-34795549,Actin
RECQL,familial ovarian cancer,SOP4,chr12:21468910-21501635,ATP-dependent DNA helicase Q1
RECQL,familial ovarian cancer,SOP4,chr12:21468910-21501635,ATP-dependent DNA helicase Q1
RECQL,hereditary breast carcinoma,SOP9,chr12:21468910-21501635,ATP-dependent DNA helicase Q1
RECQL,hereditary breast carcinoma,SOP9,chr12:21468910-21501635,ATP-dependent DNA helicase Q1
CTNNA1,hereditary nonpolyposis colon cancer,SOP4,chr5:138753425-138935034,Catenin alpha-1
CTNNA1,hereditary nonpolyposis colon cancer,SOP4,chr5:138753425-138935034,Catenin alpha-1
CTNNA1,hereditary nonpolyposis colon cancer,SOP4,chr5:138753425-138935034,Catenin alpha-1
NF1,familial ovarian cancer,SOP4,chr17:31094927-31377677,Neurofibromin
NF1,familial ovarian cancer,SOP4,chr17:31094927-31377677,Neurofibromin
CDH1,familial ovarian cancer,SOP4,chr16:68737292-68835537,Cadherin-1
CDH1,familial ovarian cancer,SOP4,chr16:68737292-68835537,Cadherin-1
CDH1,familial ovarian cancer,SOP4,chr16:68737292-68835537,Cadherin-1
MCPH1,familial ovarian cancer,SOP4,chr8:6406627-6648508,Microcephalin
MCPH1,familial ovarian cancer,SOP4,chr8:6406627-6648508,Microcephalin
MCPH1,familial ovarian cancer,SOP4,chr8:6406627-6648508,Microcephalin
MCPH1,familial ovarian cancer,SOP4,chr8:6406627-6648508,Microcephalin
MCPH1,hereditary breast carcinoma,SOP4,chr8:6406627-6648508,Microcephalin
MCPH1,hereditary breast carcinoma,SOP4,chr8:6406627-6648508,Microcephalin
MCPH1,hereditary breast carcinoma,SOP4,chr8:6406627-6648508,Microcephalin
MCPH1,hereditary breast carcinoma,SOP4,chr8:6406627-6648508,Microcephalin
TPM1,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr15:63042747-63071915,Tropomyosin alpha-1 chain
TPM1,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr15:63042747-63071915,Tropomyosin alpha-1 chain
TPM1,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr15:63042747-63071915,Tropomyosin alpha-1 chain
TPM1,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr15:63042747-63071915,Tropomyosin alpha-1 chain
TPM1,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr15:63042747-63071915,Tropomyosin alpha-1 chain
TPM1,dilated cardiomyopathy,SOP7,chr15:63042747-63071915,Tropomyosin alpha-1 chain
TPM1,dilated cardiomyopathy,SOP7,chr15:63042747-63071915,Tropomyosin alpha-1 chain
TPM1,dilated cardiomyopathy,SOP7,chr15:63042747-63071915,Tropomyosin alpha-1 chain
TPM1,dilated cardiomyopathy,SOP7,chr15:63042747-63071915,Tropomyosin alpha-1 chain
TPM1,dilated cardiomyopathy,SOP7,chr15:63042747-63071915,Tropomyosin alpha-1 chain
STK11,familial ovarian cancer,SOP4,chr19:1205778-1228431,Serine/threonine-protein kinase STK11
STK11,familial ovarian cancer,SOP4,chr19:1205778-1228431,Serine/threonine-protein kinase STK11
STK11,Peutz-Jeghers syndrome,SOP9,chr19:1205778-1228431,Serine/threonine-protein kinase STK11
STK11,Peutz-Jeghers syndrome,SOP9,chr19:1205778-1228431,Serine/threonine-protein kinase STK11
LRP2,congenital heart disease,SOP11,chr2:169127109-169362534,Low-density lipoprotein receptor-related protein 2
LRP2,congenital heart disease,SOP11,chr2:169127109-169362534,Low-density lipoprotein receptor-related protein 2
HBA1,"erythrocytosis, familial, 7",SOP10,chr16:176680-177522,Hemoglobin subunit alpha
HBA1,"erythrocytosis, familial, 7",SOP10,chr16:176680-177522,Hemoglobin subunit alpha
HBA1,"erythrocytosis, familial, 7",SOP10,chr16:176680-177522,Hemoglobin subunit alpha
HBA1,"erythrocytosis, familial, 7",SOP10,chr16:176680-177522,Hemoglobin subunit alpha
HBA1,unstable hemoglobin disease,SOP10,chr16:176680-177522,Hemoglobin subunit alpha
HBA1,unstable hemoglobin disease,SOP10,chr16:176680-177522,Hemoglobin subunit alpha
HBA1,unstable hemoglobin disease,SOP10,chr16:176680-177522,Hemoglobin subunit alpha
HBA1,unstable hemoglobin disease,SOP10,chr16:176680-177522,Hemoglobin subunit alpha
HBA1,"methemoglobinemia, alpha type",SOP9,chr16:176680-177522,Hemoglobin subunit alpha
HBA1,"methemoglobinemia, alpha type",SOP9,chr16:176680-177522,Hemoglobin subunit alpha
HBA1,"methemoglobinemia, alpha type",SOP9,chr16:176680-177522,Hemoglobin subunit alpha
HBA1,"methemoglobinemia, alpha type",SOP9,chr16:176680-177522,Hemoglobin subunit alpha
GLUL,congenital brain dysgenesis due to glutamine synthetase deficiency,SOP11,chr1:182378098-182391790,Glutamine synthetase
CACNA1C,long QT syndrome,SOP7,chr12:1970780-2697950,Voltage-dependent L-type calcium channel subunit alpha-1C
CACNA1C,long QT syndrome,SOP7,chr12:1970780-2697950,Voltage-dependent L-type calcium channel subunit alpha-1C
CACNA1C,long QT syndrome,SOP7,chr12:1970780-2697950,Voltage-dependent L-type calcium channel subunit alpha-1C
CACNA1C,long QT syndrome,SOP7,chr12:1970780-2697950,Voltage-dependent L-type calcium channel subunit alpha-1C
CACNA1C,Brugada syndrome,SOP5,chr12:1970780-2697950,Voltage-dependent L-type calcium channel subunit alpha-1C
CACNA1C,Brugada syndrome,SOP5,chr12:1970780-2697950,Voltage-dependent L-type calcium channel subunit alpha-1C
CACNA1C,Brugada syndrome,SOP5,chr12:1970780-2697950,Voltage-dependent L-type calcium channel subunit alpha-1C
CACNA1C,Brugada syndrome,SOP5,chr12:1970780-2697950,Voltage-dependent L-type calcium channel subunit alpha-1C
CACNA1C,short QT syndrome,SOP7,chr12:1970780-2697950,Voltage-dependent L-type calcium channel subunit alpha-1C
CACNA1C,short QT syndrome,SOP7,chr12:1970780-2697950,Voltage-dependent L-type calcium channel subunit alpha-1C
CACNA1C,short QT syndrome,SOP7,chr12:1970780-2697950,Voltage-dependent L-type calcium channel subunit alpha-1C
CACNA1C,short QT syndrome,SOP7,chr12:1970780-2697950,Voltage-dependent L-type calcium channel subunit alpha-1C
COL1A1,"Ehlers-Danlos syndrome, classic type, 1",SOP9,chr17:50184101-50201631,Collagen alpha-1(I) chain
COL1A1,"Ehlers-Danlos syndrome, classic type, 1",SOP9,chr17:50184101-50201631,Collagen alpha-1(I) chain
COL1A1,"Ehlers-Danlos syndrome, classic type, 1",SOP9,chr17:50184101-50201631,Collagen alpha-1(I) chain
COL1A1,"Ehlers-Danlos syndrome, classic type, 1",SOP9,chr17:50184101-50201631,Collagen alpha-1(I) chain
COL1A1,"Ehlers-Danlos syndrome, classic type, 1",SOP9,chr17:50184101-50201631,Collagen alpha-1(I) chain
COL1A1,"Ehlers-Danlos syndrome, classic type, 1",SOP9,chr17:50184101-50201631,Collagen alpha-1(I) chain
COL1A1,"Ehlers-Danlos syndrome, classic type, 1",SOP9,chr17:50184101-50201631,Collagen alpha-1(I) chain
COL1A1,"Ehlers-Danlos syndrome, classic type, 1",SOP9,chr17:50184101-50201631,Collagen alpha-1(I) chain
NSDHL,CK syndrome,SOP8,chrX:152831063-152869729,Sterol-4-alpha-carboxylate 3-dehydrogenase
NSDHL,CK syndrome,SOP8,chrX:152831063-152869729,Sterol-4-alpha-carboxylate 3-dehydrogenase
CA8,cerebellar ataxia,SOP10,chr8:60185412-60281400,Carbonic anhydrase-related protein
CA8,cerebellar ataxia,SOP10,chr8:60185412-60281400,Carbonic anhydrase-related protein
C19orf12,neurodegeneration with brain iron accumulation 4,SOP10,chr19:29698886-29715789,Protein C19orf12
GDI1,non-syndromic X-linked intellectual disability,SOP10,chrX:154437154-154443467,Rab GDP dissociation inhibitor alpha
GDI1,non-syndromic X-linked intellectual disability,SOP10,chrX:154437154-154443467,Rab GDP dissociation inhibitor alpha
EDNRB,Waardenburg syndrome type 4A,SOP9,chr13:77895481-77975527,Endothelin receptor type B
EDNRB,Waardenburg syndrome type 4A,SOP6,chr13:77895481-77975527,Endothelin receptor type B
NLGN3,X-linked complex neurodevelopmental disorder,SOP5,chrX:71144841-71175307,Neuroligin-3
FGFR1,Hartsfield-Bixler-Demyer syndrome,SOP8,chr8:38411143-38468635,Fibroblast growth factor receptor 1
FGFR1,Hartsfield-Bixler-Demyer syndrome,SOP8,chr8:38411143-38468635,Fibroblast growth factor receptor 1
FGFR1,Hartsfield-Bixler-Demyer syndrome,SOP8,chr8:38411143-38468635,Fibroblast growth factor receptor 1
FGFR1,Hartsfield-Bixler-Demyer syndrome,SOP8,chr8:38411143-38468635,Fibroblast growth factor receptor 1
FGFR1,osteoglophonic dwarfism,SOP8,chr8:38411143-38468635,Fibroblast growth factor receptor 1
FGFR1,osteoglophonic dwarfism,SOP8,chr8:38411143-38468635,Fibroblast growth factor receptor 1
FGFR1,osteoglophonic dwarfism,SOP8,chr8:38411143-38468635,Fibroblast growth factor receptor 1
FGFR1,osteoglophonic dwarfism,SOP8,chr8:38411143-38468635,Fibroblast growth factor receptor 1
BTD,Leigh syndrome,SOP7,chr3:15601361-15722516,Biotinidase
BTD,Leigh syndrome,SOP7,chr3:15601361-15722516,Biotinidase
BTD,Leigh syndrome,SOP7,chr3:15601361-15722516,Biotinidase
CSTB,developmental and epileptic encephalopathy,SOP8,chr21:43773950-43776308,Cystatin-B
CSTB,developmental and epileptic encephalopathy,SOP8,chr21:43773950-43776308,Cystatin-B
FARS2,Leigh syndrome,SOP6,chr6:5249934-5771583,Phenylalanine--tRNA ligase
DDOST,DDOST-congenital disorder of glycosylation,SOP9,chr1:20651777-20661369,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit
BPNT2,"chondrodysplasia with joint dislocations, gPAPP type",SOP10,chr8:56957931-56993867,Golgi-resident adenosine 3
COL1A2,combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2,SOP9,chr7:94394895-94431227,Collagen alpha-2(I) chain
COL1A2,combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2,SOP9,chr7:94394895-94431227,Collagen alpha-2(I) chain
COL1A2,combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2,SOP9,chr7:94394895-94431227,Collagen alpha-2(I) chain
COL1A2,combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2,SOP9,chr7:94394895-94431227,Collagen alpha-2(I) chain
COL1A2,combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2,SOP9,chr7:94394895-94431227,Collagen alpha-2(I) chain
COL1A2,combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2,SOP9,chr7:94394895-94431227,Collagen alpha-2(I) chain
COL1A2,combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2,SOP9,chr7:94394895-94431227,Collagen alpha-2(I) chain
COL1A2,combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2,SOP9,chr7:94394895-94431227,Collagen alpha-2(I) chain
COL1A2,congenital heart disease,SOP11,chr7:94394895-94431227,Collagen alpha-2(I) chain
COL1A2,congenital heart disease,SOP11,chr7:94394895-94431227,Collagen alpha-2(I) chain
COL1A2,congenital heart disease,SOP11,chr7:94394895-94431227,Collagen alpha-2(I) chain
COL1A2,congenital heart disease,SOP11,chr7:94394895-94431227,Collagen alpha-2(I) chain
COL1A2,congenital heart disease,SOP11,chr7:94394895-94431227,Collagen alpha-2(I) chain
COL1A2,congenital heart disease,SOP11,chr7:94394895-94431227,Collagen alpha-2(I) chain
COL1A2,congenital heart disease,SOP11,chr7:94394895-94431227,Collagen alpha-2(I) chain
COL1A2,congenital heart disease,SOP11,chr7:94394895-94431227,Collagen alpha-2(I) chain
CACNA1S,"malignant hyperthermia, susceptibility to, 5",SOP9,chr1:201039512-201112426,Voltage-dependent L-type calcium channel subunit alpha-1S
CACNA1S,"malignant hyperthermia, susceptibility to, 5",SOP9,chr1:201039512-201112426,Voltage-dependent L-type calcium channel subunit alpha-1S
CALM1,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr14:90396502-90408268,Calmodulin-1
CALM1,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr14:90396502-90408268,Calmodulin-1
CALM1,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr14:90396502-90408268,Calmodulin-1
EPS8,autosomal recessive nonsyndromic hearing loss 102,SOP7,chr12:15620134-15789388,Epidermal growth factor receptor kinase substrate 8
BRAF,Noonan syndrome,SOP5,chr7:140713328-140924929,Serine/threonine-protein kinase B-raf
BRAF,Noonan syndrome,SOP5,chr7:140713328-140924929,Serine/threonine-protein kinase B-raf
BRAF,Noonan syndrome,SOP5,chr7:140713328-140924929,Serine/threonine-protein kinase B-raf
BRAF,Noonan syndrome,SOP5,chr7:140713328-140924929,Serine/threonine-protein kinase B-raf
BRAF,Noonan syndrome,SOP5,chr7:140713328-140924929,Serine/threonine-protein kinase B-raf
BRAF,Noonan syndrome with multiple lentigines,SOP5,chr7:140713328-140924929,Serine/threonine-protein kinase B-raf
BRAF,Noonan syndrome with multiple lentigines,SOP5,chr7:140713328-140924929,Serine/threonine-protein kinase B-raf
BRAF,Noonan syndrome with multiple lentigines,SOP5,chr7:140713328-140924929,Serine/threonine-protein kinase B-raf
BRAF,Noonan syndrome with multiple lentigines,SOP5,chr7:140713328-140924929,Serine/threonine-protein kinase B-raf
BRAF,Noonan syndrome with multiple lentigines,SOP5,chr7:140713328-140924929,Serine/threonine-protein kinase B-raf
BRAF,Costello syndrome,SOP5,chr7:140713328-140924929,Serine/threonine-protein kinase B-raf
BRAF,Costello syndrome,SOP5,chr7:140713328-140924929,Serine/threonine-protein kinase B-raf
BRAF,Costello syndrome,SOP5,chr7:140713328-140924929,Serine/threonine-protein kinase B-raf
BRAF,Costello syndrome,SOP5,chr7:140713328-140924929,Serine/threonine-protein kinase B-raf
BRAF,Costello syndrome,SOP5,chr7:140713328-140924929,Serine/threonine-protein kinase B-raf
NDUFA1,Leigh syndrome,SOP6,chrX:119871832-119876662,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1
NDUFA10,mitochondrial disease,SOP9,chr2:239892442-240025342,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10
NDUFA10,mitochondrial disease,SOP9,chr2:239892442-240025342,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10
NDUFA10,Leigh syndrome,SOP6,chr2:239892442-240025342,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10
NDUFA10,Leigh syndrome,SOP6,chr2:239892442-240025342,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10
ABAT,developmental and epileptic encephalopathy,SOP8,chr16:8674617-8784570,4-aminobutyrate aminotransferase
ABAT,developmental and epileptic encephalopathy,SOP8,chr16:8674617-8784570,4-aminobutyrate aminotransferase
NDUFAF1,mitochondrial disease,SOP8,chr15:41387353-41403026,Complex I intermediate-associated protein 30
NDUFAF1,mitochondrial disease,SOP8,chr15:41387353-41403026,Complex I intermediate-associated protein 30
FOXE3,familial thoracic aortic aneurysm and aortic dissection,SOP4,chr1:47416285-47418052,Forkhead box protein E3
INPP5E,MORM syndrome,SOP9,chr9:136428619-136439845,Phosphatidylinositol polyphosphate 5-phosphatase type IV
INPP5E,MORM syndrome,SOP9,chr9:136428619-136439845,Phosphatidylinositol polyphosphate 5-phosphatase type IV
TBX20,congenital heart disease,SOP10,chr7:35202430-35254100,T-box transcription factor TBX20
TBX20,congenital heart disease,SOP10,chr7:35202430-35254100,T-box transcription factor TBX20
TBX20,congenital heart disease,SOP10,chr7:35202430-35254100,T-box transcription factor TBX20
TBX20,dilated cardiomyopathy,SOP7,chr7:35202430-35254100,T-box transcription factor TBX20
TBX20,dilated cardiomyopathy,SOP7,chr7:35202430-35254100,T-box transcription factor TBX20
TBX20,dilated cardiomyopathy,SOP7,chr7:35202430-35254100,T-box transcription factor TBX20
ITGB3,platelet-type bleeding disorder 16,SOP9,chr17:47253827-47313743,Integrin beta-3
ITGB3,platelet-type bleeding disorder 16,SOP9,chr17:47253827-47313743,Integrin beta-3
ITGB3,platelet-type bleeding disorder 16,SOP9,chr17:47253827-47313743,Integrin beta-3
COL2A1,"spondyloepiphyseal dysplasia, Stanescu type",SOP4,chr12:47972967-48006212,Collagen alpha-1(II) chain
COL2A1,"spondyloepiphyseal dysplasia, Stanescu type",SOP4,chr12:47972967-48006212,Collagen alpha-1(II) chain
COL2A1,"spondyloepiphyseal dysplasia, Stanescu type",SOP4,chr12:47972967-48006212,Collagen alpha-1(II) chain
COL2A1,"spondyloepiphyseal dysplasia, Stanescu type",SOP4,chr12:47972967-48006212,Collagen alpha-1(II) chain
COL2A1,"spondyloepiphyseal dysplasia, Stanescu type",SOP4,chr12:47972967-48006212,Collagen alpha-1(II) chain
COL2A1,"spondyloepiphyseal dysplasia, Stanescu type",SOP4,chr12:47972967-48006212,Collagen alpha-1(II) chain
COL2A1,"spondyloepiphyseal dysplasia, Stanescu type",SOP4,chr12:47972967-48006212,Collagen alpha-1(II) chain
COL2A1,"spondyloepiphyseal dysplasia, Stanescu type",SOP4,chr12:47972967-48006212,Collagen alpha-1(II) chain
COL2A1,"spondyloepiphyseal dysplasia, Stanescu type",SOP4,chr12:47972967-48006212,Collagen alpha-1(II) chain
COL2A1,"spondyloepiphyseal dysplasia, Stanescu type",SOP4,chr12:47972967-48006212,Collagen alpha-1(II) chain
COL2A1,spondyloepiphyseal dysplasia with metatarsal shortening,SOP9,chr12:47972967-48006212,Collagen alpha-1(II) chain
COL2A1,spondyloepiphyseal dysplasia with metatarsal shortening,SOP9,chr12:47972967-48006212,Collagen alpha-1(II) chain
COL2A1,spondyloepiphyseal dysplasia with metatarsal shortening,SOP9,chr12:47972967-48006212,Collagen alpha-1(II) chain
COL2A1,spondyloepiphyseal dysplasia with metatarsal shortening,SOP9,chr12:47972967-48006212,Collagen alpha-1(II) chain
COL2A1,spondyloepiphyseal dysplasia with metatarsal shortening,SOP9,chr12:47972967-48006212,Collagen alpha-1(II) chain
COL2A1,spondyloepiphyseal dysplasia with metatarsal shortening,SOP9,chr12:47972967-48006212,Collagen alpha-1(II) chain
COL2A1,spondyloepiphyseal dysplasia with metatarsal shortening,SOP9,chr12:47972967-48006212,Collagen alpha-1(II) chain
COL2A1,spondyloepiphyseal dysplasia with metatarsal shortening,SOP9,chr12:47972967-48006212,Collagen alpha-1(II) chain
COL2A1,spondyloepiphyseal dysplasia with metatarsal shortening,SOP9,chr12:47972967-48006212,Collagen alpha-1(II) chain
COL2A1,spondyloepiphyseal dysplasia with metatarsal shortening,SOP9,chr12:47972967-48006212,Collagen alpha-1(II) chain
ACTB,ACTB-associated syndromic thrombocytopenia,SOP10,chr7:5527148-5530601,Actin
ACTB,ACTB-associated syndromic thrombocytopenia,SOP10,chr7:5527148-5530601,Actin
ACTB,ACTB-associated syndromic thrombocytopenia,SOP10,chr7:5527148-5530601,Actin
NDUFS7,Leigh syndrome,SOP6,chr19:1383907-1395584,NADH dehydrogenase [ubiquinone] iron-sulfur protein 7
NDUFS7,Leigh syndrome,SOP6,chr19:1383907-1395584,NADH dehydrogenase [ubiquinone] iron-sulfur protein 7
NDUFS8,Leigh syndrome,SOP6,chr11:68030681-68036644,NADH dehydrogenase [ubiquinone] iron-sulfur protein 8
NDUFS8,Leigh syndrome,SOP6,chr11:68030681-68036644,NADH dehydrogenase [ubiquinone] iron-sulfur protein 8
CASQ2,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr1:115700021-115768714,Calsequestrin-2
CASQ2,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr1:115700021-115768714,Calsequestrin-2
CASQ2,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr1:115700021-115768714,Calsequestrin-2
CASQ2,hypertrophic cardiomyopathy,SOP9,chr1:115700021-115768714,Calsequestrin-2
CASQ2,hypertrophic cardiomyopathy,SOP9,chr1:115700021-115768714,Calsequestrin-2
CASQ2,hypertrophic cardiomyopathy,SOP9,chr1:115700021-115768714,Calsequestrin-2
COG1,COG1-congenital disorder of glycosylation,SOP10,chr17:73193055-73208507,Conserved oligomeric Golgi complex subunit 1
COG4,COG4-congenital disorder of glycosylation,SOP9,chr16:70480567-70523554,Conserved oligomeric Golgi complex subunit 4
SLC25A12,mitochondrial disease,SOP9,chr2:171783405-171894244,Electrogenic aspartate/glutamate antiporter SLC25A12
CALM3,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr19:46601074-46610782,Calmodulin-3
CALM3,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr19:46601074-46610782,Calmodulin-3
CALM3,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr19:46601074-46610782,Calmodulin-3
DCHS1,van Maldergem syndrome,SOP10,chr11:6621330-6655809,Protocadherin-16
DCHS1,van Maldergem syndrome,SOP10,chr11:6621330-6655809,Protocadherin-16
DCHS1,congenital heart disease,SOP10,chr11:6621330-6655809,Protocadherin-16
DCHS1,congenital heart disease,SOP10,chr11:6621330-6655809,Protocadherin-16
CALM2,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr2:47160082-47176936,Calmodulin-2
CALM2,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr2:47160082-47176936,Calmodulin-2
CALM2,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr2:47160082-47176936,Calmodulin-2
CCNQ,syndactyly-telecanthus-anogenital and renal malformations syndrome,SOP11,chrX:153587925-153599139,Cyclin-Q
GPHN,sulfite oxidase deficiency due to molybdenum cofactor deficiency type C,SOP9,chr14:66508147-67735355,Gephyrin
GPHN,sulfite oxidase deficiency due to molybdenum cofactor deficiency type C,SOP9,chr14:66508147-67735355,Gephyrin
FGFR3,camptodactyly-tall stature-scoliosis-hearing loss syndrome,SOP8,chr4:1793293-1808867,Fibroblast growth factor receptor 3
FGFR3,camptodactyly-tall stature-scoliosis-hearing loss syndrome,SOP8,chr4:1793293-1808867,Fibroblast growth factor receptor 3
FGFR3,camptodactyly-tall stature-scoliosis-hearing loss syndrome,SOP8,chr4:1793293-1808867,Fibroblast growth factor receptor 3
FGFR3,camptodactyly-tall stature-scoliosis-hearing loss syndrome,SOP8,chr4:1793293-1808867,Fibroblast growth factor receptor 3
FGFR3,camptodactyly-tall stature-scoliosis-hearing loss syndrome,SOP8,chr4:1793293-1808867,Fibroblast growth factor receptor 3
FGFR3,camptodactyly-tall stature-scoliosis-hearing loss syndrome,SOP8,chr4:1793293-1808867,Fibroblast growth factor receptor 3
FGFR3,camptodactyly-tall stature-scoliosis-hearing loss syndrome,SOP8,chr4:1793293-1808867,Fibroblast growth factor receptor 3
FGFR3,camptodactyly-tall stature-scoliosis-hearing loss syndrome,SOP8,chr4:1793293-1808867,Fibroblast growth factor receptor 3
FGFR3,camptodactyly-tall stature-scoliosis-hearing loss syndrome,SOP8,chr4:1793293-1808867,Fibroblast growth factor receptor 3
FGFR3,severe achondroplasia-developmental delay-acanthosis nigricans syndrome,SOP8,chr4:1793293-1808867,Fibroblast growth factor receptor 3
FGFR3,severe achondroplasia-developmental delay-acanthosis nigricans syndrome,SOP8,chr4:1793293-1808867,Fibroblast growth factor receptor 3
FGFR3,severe achondroplasia-developmental delay-acanthosis nigricans syndrome,SOP8,chr4:1793293-1808867,Fibroblast growth factor receptor 3
FGFR3,severe achondroplasia-developmental delay-acanthosis nigricans syndrome,SOP8,chr4:1793293-1808867,Fibroblast growth factor receptor 3
FGFR3,severe achondroplasia-developmental delay-acanthosis nigricans syndrome,SOP8,chr4:1793293-1808867,Fibroblast growth factor receptor 3
FGFR3,severe achondroplasia-developmental delay-acanthosis nigricans syndrome,SOP8,chr4:1793293-1808867,Fibroblast growth factor receptor 3
FGFR3,severe achondroplasia-developmental delay-acanthosis nigricans syndrome,SOP8,chr4:1793293-1808867,Fibroblast growth factor receptor 3
FGFR3,severe achondroplasia-developmental delay-acanthosis nigricans syndrome,SOP8,chr4:1793293-1808867,Fibroblast growth factor receptor 3
FGFR3,severe achondroplasia-developmental delay-acanthosis nigricans syndrome,SOP8,chr4:1793293-1808867,Fibroblast growth factor receptor 3
HGF,nonsyndromic genetic hearing loss,SOP10,chr7:81699010-81770047,Hepatocyte growth factor
HGF,nonsyndromic genetic hearing loss,SOP10,chr7:81699010-81770047,Hepatocyte growth factor
TSPAN7,non-syndromic X-linked intellectual disability,SOP8,chrX:38561542-38688918,Tetraspanin-7
TSPAN7,non-syndromic X-linked intellectual disability,SOP8,chrX:38561542-38688918,Tetraspanin-7
TUFM,mitochondrial disease,SOP9,chr16:28842411-28846348,Elongation factor Tu
TUFM,mitochondrial disease,SOP9,chr16:28842411-28846348,Elongation factor Tu
PSPH,neurometabolic disorder due to serine deficiency,SOP11,chr7:56011064-56051444,Phosphoserine phosphatase
PSPH,neurometabolic disorder due to serine deficiency,SOP11,chr7:56011064-56051444,Phosphoserine phosphatase
GDF2,"telangiectasia, hereditary hemorrhagic, type 5",SOP9,chr10:47322454-47327588,Growth/differentiation factor 2
GDF2,"telangiectasia, hereditary hemorrhagic, type 5",SOP9,chr10:47322454-47327588,Growth/differentiation factor 2
GFM1,Leigh syndrome,SOP6,chr3:158644527-158695581,Elongation factor G
GFM1,Leigh syndrome,SOP6,chr3:158644527-158695581,Elongation factor G
TTN,tibial muscular dystrophy,SOP8,chr2:178525989-178807423,Titin
TTN,tibial muscular dystrophy,SOP8,chr2:178525989-178807423,Titin
TTN,tibial muscular dystrophy,SOP8,chr2:178525989-178807423,Titin
TTN,tibial muscular dystrophy,SOP8,chr2:178525989-178807423,Titin
TTN,tibial muscular dystrophy,SOP8,chr2:178525989-178807423,Titin
TTN,tibial muscular dystrophy,SOP8,chr2:178525989-178807423,Titin
TTN,tibial muscular dystrophy,SOP8,chr2:178525989-178807423,Titin
TTN,"myopathy, myofibrillar, 9, with early respiratory failure",SOP8,chr2:178525989-178807423,Titin
TTN,"myopathy, myofibrillar, 9, with early respiratory failure",SOP8,chr2:178525989-178807423,Titin
TTN,"myopathy, myofibrillar, 9, with early respiratory failure",SOP8,chr2:178525989-178807423,Titin
TTN,"myopathy, myofibrillar, 9, with early respiratory failure",SOP8,chr2:178525989-178807423,Titin
TTN,"myopathy, myofibrillar, 9, with early respiratory failure",SOP8,chr2:178525989-178807423,Titin
TTN,"myopathy, myofibrillar, 9, with early respiratory failure",SOP8,chr2:178525989-178807423,Titin
TTN,"myopathy, myofibrillar, 9, with early respiratory failure",SOP8,chr2:178525989-178807423,Titin
TTN,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr2:178525989-178807423,Titin
TTN,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr2:178525989-178807423,Titin
TTN,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr2:178525989-178807423,Titin
TTN,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr2:178525989-178807423,Titin
TTN,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr2:178525989-178807423,Titin
TTN,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr2:178525989-178807423,Titin
TTN,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr2:178525989-178807423,Titin
TTN,hypertrophic cardiomyopathy,SOP9,chr2:178525989-178807423,Titin
TTN,hypertrophic cardiomyopathy,SOP9,chr2:178525989-178807423,Titin
TTN,hypertrophic cardiomyopathy,SOP9,chr2:178525989-178807423,Titin
TTN,hypertrophic cardiomyopathy,SOP9,chr2:178525989-178807423,Titin
TTN,hypertrophic cardiomyopathy,SOP9,chr2:178525989-178807423,Titin
TTN,hypertrophic cardiomyopathy,SOP9,chr2:178525989-178807423,Titin
TTN,hypertrophic cardiomyopathy,SOP9,chr2:178525989-178807423,Titin
DNM1,developmental and epileptic encephalopathy,SOP10,chr9:128203379-128255244,Dynamin-1
IGLL1,"agammaglobulinemia 2, autosomal recessive",SOP8,chr22:23573125-23580290,Immunoglobulin lambda-like polypeptide 1
WRAP53,dyskeratosis congenita,SOP4,chr17:7686071-7703502,Telomerase Cajal body protein 1
WRAP53,dyskeratosis congenita,SOP4,chr17:7686071-7703502,Telomerase Cajal body protein 1
MTAP,diaphyseal medullary stenosis-bone malignancy syndrome,SOP8,chr9:21802636-21941115,S-methyl-5'-thioadenosine phosphorylase
PAX5,PAX5-related B lymphopenia and autism spectrum disorder,SOP9,chr9:36833269-37034268,Paired box protein Pax-5
PAX5,PAX5-related B lymphopenia and autism spectrum disorder,SOP9,chr9:36833269-37034268,Paired box protein Pax-5
KDM5B,intellectual disability,SOP9,chr1:202724495-202808421,Lysine-specific demethylase 5B
SUCLG1,Leigh syndrome,SOP6,chr2:84423528-84459280,Succinate--CoA ligase [ADP/GDP-forming] subunit alpha
SUCLG1,Leigh syndrome,SOP6,chr2:84423528-84459280,Succinate--CoA ligase [ADP/GDP-forming] subunit alpha
ORC4,Meier-Gorlin syndrome 2,SOP9,chr2:147930396-148021551,Origin recognition complex subunit 4
TRMU,Leigh syndrome,SOP7,chr22:46335714-46357340,Mitochondrial tRNA-specific 2-thiouridylase 1
TRMU,Leigh syndrome,SOP7,chr22:46335714-46357340,Mitochondrial tRNA-specific 2-thiouridylase 1
TRMU,Leigh syndrome,SOP7,chr22:46335714-46357340,Mitochondrial tRNA-specific 2-thiouridylase 1
SYNE4,nonsyndromic genetic hearing loss,SOP7,chr19:36003307-36008813,Nesprin-4
SYNE4,nonsyndromic genetic hearing loss,SOP7,chr19:36003307-36008813,Nesprin-4
GRIK2,complex neurodevelopmental disorder,SOP8,chr6:101393708-102070083,Glutamate receptor ionotropic
GRIK2,complex neurodevelopmental disorder,SOP8,chr6:101393708-102070083,Glutamate receptor ionotropic
WHRN,nonsyndromic genetic hearing loss,SOP10,chr9:114402080-114505473,Whirlin
WHRN,nonsyndromic genetic hearing loss,SOP10,chr9:114402080-114505473,Whirlin
WHRN,nonsyndromic genetic hearing loss,SOP10,chr9:114402080-114505473,Whirlin
SYP,non-syndromic X-linked intellectual disability,SOP8,chrX:49187815-49200193,Synaptophysin
SYP,non-syndromic X-linked intellectual disability,SOP8,chrX:49187815-49200193,Synaptophysin
PDSS2,Leigh syndrome,SOP7,chr6:107152562-107459564,All trans-polyprenyl-diphosphate synthase PDSS2
PDSS2,Leigh syndrome,SOP7,chr6:107152562-107459564,All trans-polyprenyl-diphosphate synthase PDSS2
PDX1,monogenic diabetes,SOP9,chr13:27920000-27926313,Pancreas/duodenum homeobox protein 1
PDX1,monogenic diabetes,SOP9,chr13:27920000-27926313,Pancreas/duodenum homeobox protein 1
TPK1,Leigh syndrome,SOP7,chr7:144451941-144836437,Thiamine pyrophosphokinase 1
TPK1,Leigh syndrome,SOP7,chr7:144451941-144836437,Thiamine pyrophosphokinase 1
ALAD,porphyria due to ALA dehydratase deficiency,SOP10,chr9:113386312-113401284,Delta-aminolevulinic acid dehydratase
TWIST1,TWIST1-related craniosynostosis,SOP8,chr7:19113047-19117636,Twist-related protein 1
TWIST1,TWIST1-related craniosynostosis,SOP8,chr7:19113047-19117636,Twist-related protein 1
TWIST1,TWIST1-related craniosynostosis,SOP8,chr7:19113047-19117636,Twist-related protein 1
TWIST1,Sweeney-Cox syndrome,SOP8,chr7:19113047-19117636,Twist-related protein 1
TWIST1,Sweeney-Cox syndrome,SOP8,chr7:19113047-19117636,Twist-related protein 1
TWIST1,Sweeney-Cox syndrome,SOP8,chr7:19113047-19117636,Twist-related protein 1
DPM3,DPM3-congenital disorder of glycosylation,SOP10,chr1:155139891-155140531,Dolichol-phosphate mannosyltransferase subunit 3
ATP7A,X-linked distal spinal muscular atrophy type 3,SOP9,chrX:77910693-78050395,Copper-transporting ATPase 1
ATP7A,X-linked distal spinal muscular atrophy type 3,SOP9,chrX:77910693-78050395,Copper-transporting ATPase 1
LITAF,Charcot-Marie-Tooth disease,SOP7,chr16:11547722-11640317,Lipopolysaccharide-induced tumor necrosis factor-alpha factor
LITAF,Charcot-Marie-Tooth disease,SOP7,chr16:11547722-11640317,Lipopolysaccharide-induced tumor necrosis factor-alpha factor
LITAF,Charcot-Marie-Tooth disease,SOP7,chr16:11547722-11640317,Lipopolysaccharide-induced tumor necrosis factor-alpha factor
LBR,regressive spondylometaphyseal dysplasia,SOP10,chr1:225401502-225428821,Delta(14)-sterol reductase LBR
LBR,regressive spondylometaphyseal dysplasia,SOP10,chr1:225401502-225428821,Delta(14)-sterol reductase LBR
LBR,Greenberg dysplasia,SOP10,chr1:225401502-225428821,Delta(14)-sterol reductase LBR
LBR,Greenberg dysplasia,SOP10,chr1:225401502-225428821,Delta(14)-sterol reductase LBR
SERPINB6,nonsyndromic genetic hearing loss,SOP9,chr6:2948159-2971793,Serpin B6
SERPINB6,nonsyndromic genetic hearing loss,SOP9,chr6:2948159-2971793,Serpin B6
FOXRED1,Leigh syndrome,SOP6,chr11:126269154-126278126,FAD-dependent oxidoreductase domain-containing protein 1
FOXRED1,Leigh syndrome,SOP6,chr11:126269154-126278126,FAD-dependent oxidoreductase domain-containing protein 1
PMM2,hyperinsulinemic hypoglycemia with polycystic kidney disease,SOP10,chr16:8797839-8849325,Phosphomannomutase 2
PMM2,hyperinsulinemic hypoglycemia with polycystic kidney disease,SOP10,chr16:8797839-8849325,Phosphomannomutase 2
PMM2,PMM2-congenital disorder of glycosylation,SOP10,chr16:8797839-8849325,Phosphomannomutase 2
PMM2,PMM2-congenital disorder of glycosylation,SOP10,chr16:8797839-8849325,Phosphomannomutase 2
SOX3,SOX3-related X-linked pituitary hormone deficiency with or without intellectual developmental disorder,SOP10,chrX:140502985-140505069,Transcription factor SOX-3
SOX3,SOX3-related X-linked pituitary hormone deficiency with or without intellectual developmental disorder,SOP10,chrX:140502985-140505069,Transcription factor SOX-3
COX10,Leigh syndrome,SOP6,chr17:14069504-14208677,Protoheme IX farnesyltransferase
COX10,Leigh syndrome,SOP6,chr17:14069504-14208677,Protoheme IX farnesyltransferase
SDHAF1,Leigh syndrome,SOP7,chr19:35995188-35996312,Succinate dehydrogenase assembly factor 1
SDHAF1,Leigh syndrome,SOP7,chr19:35995188-35996312,Succinate dehydrogenase assembly factor 1
SDHAF1,Leigh syndrome,SOP7,chr19:35995188-35996312,Succinate dehydrogenase assembly factor 1
SDHAF1,mitochondrial disease,SOP10,chr19:35995188-35996312,Succinate dehydrogenase assembly factor 1
SDHAF1,mitochondrial disease,SOP10,chr19:35995188-35996312,Succinate dehydrogenase assembly factor 1
SDHAF1,mitochondrial disease,SOP10,chr19:35995188-35996312,Succinate dehydrogenase assembly factor 1
CTNNA3,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr10:65912523-67763594,Catenin alpha-3
CTNNA3,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr10:65912523-67763594,Catenin alpha-3
CTNNA3,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr10:65912523-67763594,Catenin alpha-3
CTNNA3,congenital heart disease,SOP10,chr10:65912523-67763594,Catenin alpha-3
CTNNA3,congenital heart disease,SOP10,chr10:65912523-67763594,Catenin alpha-3
CTNNA3,congenital heart disease,SOP10,chr10:65912523-67763594,Catenin alpha-3
DISP1,holoprosencephaly,SOP9,chr1:222815039-223005995,Protein dispatched homolog 1
BLM,colorectal cancer,SOP11,chr15:90717346-90816166,RecQ-like DNA helicase BLM
BLM,colorectal cancer,SOP11,chr15:90717346-90816166,RecQ-like DNA helicase BLM
ENPP1,hypopigmentation-punctate palmoplantar keratoderma syndrome,SOP8,chr6:131808020-131895155,Ectonucleotide pyrophosphatase/phosphodiesterase family member 1
ENPP1,hypopigmentation-punctate palmoplantar keratoderma syndrome,SOP8,chr6:131808020-131895155,Ectonucleotide pyrophosphatase/phosphodiesterase family member 1
ENPP1,hypopigmentation-punctate palmoplantar keratoderma syndrome,SOP8,chr6:131808020-131895155,Ectonucleotide pyrophosphatase/phosphodiesterase family member 1
DNMT3A,Heyn-Sproul-Jackson syndrome,SOP9,chr2:25227874-25342590,DNA (cytosine-5)-methyltransferase 3A
DNMT3A,Heyn-Sproul-Jackson syndrome,SOP9,chr2:25227874-25342590,DNA (cytosine-5)-methyltransferase 3A
RAF1,Noonan syndrome with multiple lentigines,SOP5,chr3:12583601-12664117,RAF proto-oncogene serine/threonine-protein kinase
RAF1,Noonan syndrome with multiple lentigines,SOP5,chr3:12583601-12664117,RAF proto-oncogene serine/threonine-protein kinase
RAF1,Noonan syndrome with multiple lentigines,SOP5,chr3:12583601-12664117,RAF proto-oncogene serine/threonine-protein kinase
RAF1,Noonan syndrome with multiple lentigines,SOP5,chr3:12583601-12664117,RAF proto-oncogene serine/threonine-protein kinase
RAF1,Noonan syndrome with multiple lentigines,SOP5,chr3:12583601-12664117,RAF proto-oncogene serine/threonine-protein kinase
RAF1,Costello syndrome,SOP5,chr3:12583601-12664117,RAF proto-oncogene serine/threonine-protein kinase
RAF1,Costello syndrome,SOP5,chr3:12583601-12664117,RAF proto-oncogene serine/threonine-protein kinase
RAF1,Costello syndrome,SOP5,chr3:12583601-12664117,RAF proto-oncogene serine/threonine-protein kinase
RAF1,Costello syndrome,SOP5,chr3:12583601-12664117,RAF proto-oncogene serine/threonine-protein kinase
RAF1,Costello syndrome,SOP5,chr3:12583601-12664117,RAF proto-oncogene serine/threonine-protein kinase
RAF1,cardiofaciocutaneous syndrome,SOP5,chr3:12583601-12664117,RAF proto-oncogene serine/threonine-protein kinase
RAF1,cardiofaciocutaneous syndrome,SOP5,chr3:12583601-12664117,RAF proto-oncogene serine/threonine-protein kinase
RAF1,cardiofaciocutaneous syndrome,SOP5,chr3:12583601-12664117,RAF proto-oncogene serine/threonine-protein kinase
RAF1,cardiofaciocutaneous syndrome,SOP5,chr3:12583601-12664117,RAF proto-oncogene serine/threonine-protein kinase
RAF1,cardiofaciocutaneous syndrome,SOP5,chr3:12583601-12664117,RAF proto-oncogene serine/threonine-protein kinase
DMXL2,nonsyndromic genetic hearing loss,SOP7,chr15:51447791-51622771,DmX-like protein 2
MAP2K2,Noonan syndrome,SOP5,chr19:4090321-4124122,Dual specificity mitogen-activated protein kinase kinase 2
MAP2K2,Noonan syndrome,SOP5,chr19:4090321-4124122,Dual specificity mitogen-activated protein kinase kinase 2
CRIPTO,congenital heart disease,SOP10,chr3:46574535-46582457,Protein Cripto
COX15,Leigh syndrome,SOP6,chr10:99694293-99732127,Heme A synthase COX15
COX15,Leigh syndrome,SOP6,chr10:99694293-99732127,Heme A synthase COX15
COX15,Leigh syndrome,SOP6,chr10:99694293-99732127,Heme A synthase COX15
CYLD,frontotemporal dementia and/or amyotrophic lateral sclerosis 8,SOP9,chr16:50742086-50801935,Ubiquitin carboxyl-terminal hydrolase CYLD
CYLD,frontotemporal dementia and/or amyotrophic lateral sclerosis 8,SOP9,chr16:50742086-50801935,Ubiquitin carboxyl-terminal hydrolase CYLD
SMARCA4,hereditary nonpolyposis colon cancer,SOP4,chr19:10961030-11062273,Transcription activator BRG1
SMARCA4,hereditary nonpolyposis colon cancer,SOP4,chr19:10961030-11062273,Transcription activator BRG1
SMARCA4,hereditary nonpolyposis colon cancer,SOP4,chr19:10961030-11062273,Transcription activator BRG1
SMARCA4,hereditary nonpolyposis colon cancer,SOP4,chr19:10961030-11062273,Transcription activator BRG1
SMARCA4,Coffin-Siris syndrome,SOP7,chr19:10961030-11062273,Transcription activator BRG1
SMARCA4,Coffin-Siris syndrome,SOP7,chr19:10961030-11062273,Transcription activator BRG1
SMARCA4,Coffin-Siris syndrome,SOP7,chr19:10961030-11062273,Transcription activator BRG1
SMARCA4,Coffin-Siris syndrome,SOP7,chr19:10961030-11062273,Transcription activator BRG1
SMARCA4,rhabdoid tumor predisposition syndrome 2,SOP5,chr19:10961030-11062273,Transcription activator BRG1
SMARCA4,rhabdoid tumor predisposition syndrome 2,SOP5,chr19:10961030-11062273,Transcription activator BRG1
SMARCA4,rhabdoid tumor predisposition syndrome 2,SOP5,chr19:10961030-11062273,Transcription activator BRG1
SMARCA4,rhabdoid tumor predisposition syndrome 2,SOP5,chr19:10961030-11062273,Transcription activator BRG1
MAP2K1,Noonan syndrome,SOP5,chr15:66386912-66491544,Dual specificity mitogen-activated protein kinase kinase 1
MAP2K1,Noonan syndrome,SOP5,chr15:66386912-66491544,Dual specificity mitogen-activated protein kinase kinase 1
MAP2K1,Noonan syndrome,SOP5,chr15:66386912-66491544,Dual specificity mitogen-activated protein kinase kinase 1
MAP2K1,Noonan syndrome,SOP5,chr15:66386912-66491544,Dual specificity mitogen-activated protein kinase kinase 1
MAP2K1,Noonan syndrome with multiple lentigines,SOP5,chr15:66386912-66491544,Dual specificity mitogen-activated protein kinase kinase 1
MAP2K1,Noonan syndrome with multiple lentigines,SOP5,chr15:66386912-66491544,Dual specificity mitogen-activated protein kinase kinase 1
MAP2K1,Noonan syndrome with multiple lentigines,SOP5,chr15:66386912-66491544,Dual specificity mitogen-activated protein kinase kinase 1
MAP2K1,Noonan syndrome with multiple lentigines,SOP5,chr15:66386912-66491544,Dual specificity mitogen-activated protein kinase kinase 1
MAP2K1,Costello syndrome,SOP5,chr15:66386912-66491544,Dual specificity mitogen-activated protein kinase kinase 1
MAP2K1,Costello syndrome,SOP5,chr15:66386912-66491544,Dual specificity mitogen-activated protein kinase kinase 1
MAP2K1,Costello syndrome,SOP5,chr15:66386912-66491544,Dual specificity mitogen-activated protein kinase kinase 1
MAP2K1,Costello syndrome,SOP5,chr15:66386912-66491544,Dual specificity mitogen-activated protein kinase kinase 1
DLGAP2,complex neurodevelopmental disorder,SOP8,chr8:737628-1708476,Disks large-associated protein 2
ENG,juvenile polyposis syndrome,SOP9,chr9:127815016-127854658,Endoglin
ENG,juvenile polyposis syndrome,SOP9,chr9:127815016-127854658,Endoglin
ENG,juvenile polyposis syndrome,SOP9,chr9:127815016-127854658,Endoglin
MYBPC3,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr11:47331406-47352702,Myosin-binding protein C
MYBPC3,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr11:47331406-47352702,Myosin-binding protein C
MYBPC3,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr11:47331406-47352702,Myosin-binding protein C
MYBPC3,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr11:47331406-47352702,Myosin-binding protein C
MYBPC3,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr11:47331406-47352702,Myosin-binding protein C
MYBPC3,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr11:47331406-47352702,Myosin-binding protein C
MYBPC3,congenital heart disease,SOP10,chr11:47331406-47352702,Myosin-binding protein C
MYBPC3,congenital heart disease,SOP10,chr11:47331406-47352702,Myosin-binding protein C
MYBPC3,congenital heart disease,SOP10,chr11:47331406-47352702,Myosin-binding protein C
MYBPC3,congenital heart disease,SOP10,chr11:47331406-47352702,Myosin-binding protein C
MYBPC3,congenital heart disease,SOP10,chr11:47331406-47352702,Myosin-binding protein C
MYBPC3,congenital heart disease,SOP10,chr11:47331406-47352702,Myosin-binding protein C
MYBPC3,dilated cardiomyopathy,SOP7,chr11:47331406-47352702,Myosin-binding protein C
MYBPC3,dilated cardiomyopathy,SOP7,chr11:47331406-47352702,Myosin-binding protein C
MYBPC3,dilated cardiomyopathy,SOP7,chr11:47331406-47352702,Myosin-binding protein C
MYBPC3,dilated cardiomyopathy,SOP7,chr11:47331406-47352702,Myosin-binding protein C
MYBPC3,dilated cardiomyopathy,SOP7,chr11:47331406-47352702,Myosin-binding protein C
MYBPC3,dilated cardiomyopathy,SOP7,chr11:47331406-47352702,Myosin-binding protein C
MYH7,congenital heart disease,SOP10,chr14:23412740-23435660,Myosin-7
MYH7,congenital heart disease,SOP10,chr14:23412740-23435660,Myosin-7
MYH7,congenital heart disease,SOP10,chr14:23412740-23435660,Myosin-7
MYH7,congenital heart disease,SOP10,chr14:23412740-23435660,Myosin-7
MYH7,congenital heart disease,SOP10,chr14:23412740-23435660,Myosin-7
MYH7,congenital heart disease,SOP10,chr14:23412740-23435660,Myosin-7
MYH7,congenital heart disease,SOP10,chr14:23412740-23435660,Myosin-7
MYH7,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr14:23412740-23435660,Myosin-7
MYH7,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr14:23412740-23435660,Myosin-7
MYH7,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr14:23412740-23435660,Myosin-7
MYH7,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr14:23412740-23435660,Myosin-7
MYH7,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr14:23412740-23435660,Myosin-7
MYH7,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr14:23412740-23435660,Myosin-7
MYH7,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr14:23412740-23435660,Myosin-7
MED13L,congenital heart disease,SOP10,chr12:115958576-116277693,Mediator of RNA polymerase II transcription subunit 13-like
MED13L,congenital heart disease,SOP10,chr12:115958576-116277693,Mediator of RNA polymerase II transcription subunit 13-like
COL9A2,Stickler syndrome,SOP6,chr1:40300489-40317286,Collagen alpha-2(IX) chain
DNASE1,systemic lupus erythematosus,SOP10,chr16:3611760-3665461,Deoxyribonuclease-1
MYL3,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr3:46857872-46882182,Myosin light chain 3
MYL3,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr3:46857872-46882182,Myosin light chain 3
MYL3,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr3:46857872-46882182,Myosin light chain 3
MYL3,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr3:46857872-46882182,Myosin light chain 3
MYL3,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr3:46857872-46882182,Myosin light chain 3
MYL3,dilated cardiomyopathy,SOP7,chr3:46857872-46882182,Myosin light chain 3
MYL3,dilated cardiomyopathy,SOP7,chr3:46857872-46882182,Myosin light chain 3
MYL3,dilated cardiomyopathy,SOP7,chr3:46857872-46882182,Myosin light chain 3
MYL3,dilated cardiomyopathy,SOP7,chr3:46857872-46882182,Myosin light chain 3
MYL3,dilated cardiomyopathy,SOP7,chr3:46857872-46882182,Myosin light chain 3
SCN5A,arrhythmogenic right ventricular cardiomyopathy,SOP6,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,arrhythmogenic right ventricular cardiomyopathy,SOP6,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,arrhythmogenic right ventricular cardiomyopathy,SOP6,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,arrhythmogenic right ventricular cardiomyopathy,SOP6,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,arrhythmogenic right ventricular cardiomyopathy,SOP6,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,arrhythmogenic right ventricular cardiomyopathy,SOP6,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,arrhythmogenic right ventricular cardiomyopathy,SOP6,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,arrhythmogenic right ventricular cardiomyopathy,SOP6,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,arrhythmogenic right ventricular cardiomyopathy,SOP6,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,arrhythmogenic right ventricular cardiomyopathy,SOP6,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,short QT syndrome,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,short QT syndrome,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,short QT syndrome,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,short QT syndrome,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,short QT syndrome,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,short QT syndrome,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,short QT syndrome,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,short QT syndrome,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,short QT syndrome,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,short QT syndrome,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,congenital heart disease,SOP11,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,congenital heart disease,SOP11,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,congenital heart disease,SOP11,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,congenital heart disease,SOP11,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,congenital heart disease,SOP11,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,congenital heart disease,SOP11,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,congenital heart disease,SOP11,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,congenital heart disease,SOP11,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,congenital heart disease,SOP11,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,congenital heart disease,SOP11,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,dilated cardiomyopathy,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,dilated cardiomyopathy,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,dilated cardiomyopathy,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,dilated cardiomyopathy,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,dilated cardiomyopathy,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,dilated cardiomyopathy,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,dilated cardiomyopathy,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,dilated cardiomyopathy,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,dilated cardiomyopathy,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,dilated cardiomyopathy,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,familial long QT syndrome,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,familial long QT syndrome,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,familial long QT syndrome,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,familial long QT syndrome,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,familial long QT syndrome,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,familial long QT syndrome,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,familial long QT syndrome,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,familial long QT syndrome,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,familial long QT syndrome,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
SCN5A,familial long QT syndrome,SOP7,chr3:38548062-38649687,Sodium channel protein type 5 subunit alpha
MET,nonsyndromic genetic hearing loss,SOP8,chr7:116672196-116798377,Hepatocyte growth factor receptor
MET,nonsyndromic genetic hearing loss,SOP8,chr7:116672196-116798377,Hepatocyte growth factor receptor
MET,nonsyndromic genetic hearing loss,SOP8,chr7:116672196-116798377,Hepatocyte growth factor receptor
MET,nonsyndromic genetic hearing loss,SOP8,chr7:116672196-116798377,Hepatocyte growth factor receptor
MET,complex neurodevelopmental disorder,SOP8,chr7:116672196-116798377,Hepatocyte growth factor receptor
MET,complex neurodevelopmental disorder,SOP8,chr7:116672196-116798377,Hepatocyte growth factor receptor
MET,complex neurodevelopmental disorder,SOP8,chr7:116672196-116798377,Hepatocyte growth factor receptor
MET,complex neurodevelopmental disorder,SOP8,chr7:116672196-116798377,Hepatocyte growth factor receptor
DSG2,dilated cardiomyopathy,SOP7,chr18:31498177-31549008,Desmoglein-2
DSG2,dilated cardiomyopathy,SOP7,chr18:31498177-31549008,Desmoglein-2
DSG2,dilated cardiomyopathy,SOP7,chr18:31498177-31549008,Desmoglein-2
DSG2,dilated cardiomyopathy,SOP7,chr18:31498177-31549008,Desmoglein-2
CNTN4,complex neurodevelopmental disorder,SOP9,chr3:2098866-3057959,Contactin-4
CNOT1,holoprosencephaly 12 with or without pancreatic agenesis,SOP9,chr16:58519951-58629826,CCR4-NOT transcription complex subunit 1
CNOT1,holoprosencephaly 12 with or without pancreatic agenesis,SOP9,chr16:58519951-58629826,CCR4-NOT transcription complex subunit 1
PSD3,antecubital pterygium syndrome,SOP4,chr8:18527303-19084805,PH and SEC7 domain-containing protein 3
FANCM,hereditary breast carcinoma,SOP11,chr14:45135930-45200890,Fanconi anemia group M protein
NOTCH1,familial thoracic aortic aneurysm and aortic dissection,SOP4,chr9:136494433-136546048,Neurogenic locus notch homolog protein 1
NOTCH1,familial thoracic aortic aneurysm and aortic dissection,SOP4,chr9:136494433-136546048,Neurogenic locus notch homolog protein 1
SDHD,mitochondrial disease,SOP8,chr11:112086873-112095794,Succinate dehydrogenase [ubiquinone] cytochrome b small subunit
SDHD,mitochondrial disease,SOP8,chr11:112086873-112095794,Succinate dehydrogenase [ubiquinone] cytochrome b small subunit
SDHD,mitochondrial disease,SOP8,chr11:112086873-112095794,Succinate dehydrogenase [ubiquinone] cytochrome b small subunit
SDHD,mitochondrial disease,SOP8,chr11:112086873-112095794,Succinate dehydrogenase [ubiquinone] cytochrome b small subunit
SDHD,mitochondrial disease,SOP8,chr11:112086873-112095794,Succinate dehydrogenase [ubiquinone] cytochrome b small subunit
SDHD,hereditary pheochromocytoma-paraganglioma,SOP8,chr11:112086873-112095794,Succinate dehydrogenase [ubiquinone] cytochrome b small subunit
SDHD,hereditary pheochromocytoma-paraganglioma,SOP8,chr11:112086873-112095794,Succinate dehydrogenase [ubiquinone] cytochrome b small subunit
SDHD,hereditary pheochromocytoma-paraganglioma,SOP8,chr11:112086873-112095794,Succinate dehydrogenase [ubiquinone] cytochrome b small subunit
SDHD,hereditary pheochromocytoma-paraganglioma,SOP8,chr11:112086873-112095794,Succinate dehydrogenase [ubiquinone] cytochrome b small subunit
SDHD,hereditary pheochromocytoma-paraganglioma,SOP8,chr11:112086873-112095794,Succinate dehydrogenase [ubiquinone] cytochrome b small subunit
COX14,mitochondrial disease,SOP8,chr12:50112236-50120453,Cytochrome c oxidase assembly protein COX14
COX14,mitochondrial disease,SOP8,chr12:50112236-50120453,Cytochrome c oxidase assembly protein COX14
MYH11,congenital heart disease,SOP11,chr16:15703135-15857028,Myosin-11
MYH11,congenital heart disease,SOP11,chr16:15703135-15857028,Myosin-11
NHP2,dyskeratosis congenita,SOP4,chr5:178149463-178153885,H/ACA ribonucleoprotein complex subunit 2
NHP2,dyskeratosis congenita,SOP4,chr5:178149463-178153885,H/ACA ribonucleoprotein complex subunit 2
ROBO1,congenital heart disease,SOP10,chr3:78597239-79767998,Roundabout homolog 1
ROBO1,congenital heart disease,SOP10,chr3:78597239-79767998,Roundabout homolog 1
ERBB4,amyotrophic lateral sclerosis type 19,SOP8,chr2:211375717-212538802,Receptor tyrosine-protein kinase erbB-4
ERBB4,amyotrophic lateral sclerosis type 19,SOP8,chr2:211375717-212538802,Receptor tyrosine-protein kinase erbB-4
NAT8L,N-acetylaspartate deficiency,SOP10,chr4:2059327-2069089,N-acetylaspartate synthetase
GJA1,congenital heart disease,SOP10,chr6:121435646-121449727,Gap junction alpha-1 protein
GJA1,congenital heart disease,SOP10,chr6:121435646-121449727,Gap junction alpha-1 protein
GJA1,nonsyndromic genetic hearing loss,SOP8,chr6:121435646-121449727,Gap junction alpha-1 protein
GJA1,nonsyndromic genetic hearing loss,SOP8,chr6:121435646-121449727,Gap junction alpha-1 protein
KDM6B,syndromic intellectual disability,SOP8,chr17:7834217-7854796,Lysine-specific demethylase 6B
SOX9,Cooks syndrome,SOP7,chr17:72121020-72126416,Transcription factor SOX-9
SOX9,Cooks syndrome,SOP7,chr17:72121020-72126416,Transcription factor SOX-9
SOX9,Cooks syndrome,SOP7,chr17:72121020-72126416,Transcription factor SOX-9
SOX9,isolated Pierre-Robin syndrome,SOP10,chr17:72121020-72126416,Transcription factor SOX-9
SOX9,isolated Pierre-Robin syndrome,SOP10,chr17:72121020-72126416,Transcription factor SOX-9
SOX9,isolated Pierre-Robin syndrome,SOP10,chr17:72121020-72126416,Transcription factor SOX-9
SOX9,campomelic dysplasia,SOP7,chr17:72121020-72126416,Transcription factor SOX-9
SOX9,campomelic dysplasia,SOP7,chr17:72121020-72126416,Transcription factor SOX-9
SOX9,campomelic dysplasia,SOP7,chr17:72121020-72126416,Transcription factor SOX-9
USH1C,nonsyndromic genetic hearing loss,SOP6,chr11:17493900-17544416,Harmonin
USH1C,nonsyndromic genetic hearing loss,SOP6,chr11:17493900-17544416,Harmonin
USH1C,nonsyndromic genetic hearing loss,SOP6,chr11:17493900-17544416,Harmonin
OTUD7A,complex neurodevelopmental disorder,SOP9,chr15:31475398-31870673,OTU domain-containing protein 7A
ATP6V1E1,autosomal recessive cutis laxa type 2C,SOP10,chr22:17592136-17628822,V-type proton ATPase subunit E 1
VEGFA,congenital heart disease,SOP10,chr6:43770211-43786487,Vascular endothelial growth factor A
ATPAF2,mitochondrial disease,SOP8,chr17:18015059-18039168,ATP synthase mitochondrial F1 complex assembly factor 2
ATPAF2,mitochondrial disease,SOP8,chr17:18015059-18039168,ATP synthase mitochondrial F1 complex assembly factor 2
SOBP,syndromic intellectual disability,SOP9,chr6:107490117-107661306,Sine oculis-binding protein homolog
SOBP,syndromic intellectual disability,SOP9,chr6:107490117-107661306,Sine oculis-binding protein homolog
RAD51C,Fanconi anemia complementation group O,SOP9,chr17:58692573-58735611,DNA repair protein RAD51 homolog 3
RAD51C,Fanconi anemia complementation group O,SOP9,chr17:58692573-58735611,DNA repair protein RAD51 homolog 3
RAD51C,Fanconi anemia complementation group O,SOP9,chr17:58692573-58735611,DNA repair protein RAD51 homolog 3
RAD51C,Fanconi anemia complementation group O,SOP9,chr17:58692573-58735611,DNA repair protein RAD51 homolog 3
RAD51C,RAD51C-related cancer predisposition,SOP10,chr17:58692573-58735611,DNA repair protein RAD51 homolog 3
RAD51C,RAD51C-related cancer predisposition,SOP10,chr17:58692573-58735611,DNA repair protein RAD51 homolog 3
RAD51C,RAD51C-related cancer predisposition,SOP10,chr17:58692573-58735611,DNA repair protein RAD51 homolog 3
RAD51C,RAD51C-related cancer predisposition,SOP10,chr17:58692573-58735611,DNA repair protein RAD51 homolog 3
NR3C2,pseudohyperaldosteronism type 2,SOP8,chr4:148078764-148445508,Mineralocorticoid receptor
NR3C2,pseudohyperaldosteronism type 2,SOP8,chr4:148078764-148445508,Mineralocorticoid receptor
LMNA,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr1:156082573-156140081,Prelamin-A/C
LMNA,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr1:156082573-156140081,Prelamin-A/C
LMNA,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr1:156082573-156140081,Prelamin-A/C
LMNA,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr1:156082573-156140081,Prelamin-A/C
LMNA,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr1:156082573-156140081,Prelamin-A/C
LMNA,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr1:156082573-156140081,Prelamin-A/C
LMNA,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr1:156082573-156140081,Prelamin-A/C
BCS1L,Leigh syndrome,SOP6,chr2:218658743-218663443,Mitochondrial chaperone BCS1
BCS1L,Leigh syndrome,SOP6,chr2:218658743-218663443,Mitochondrial chaperone BCS1
PRPS1,phosphoribosylpyrophosphate synthetase superactivity,SOP7,chrX:107628510-107651026,Ribose-phosphate pyrophosphokinase 1
PRPS1,phosphoribosylpyrophosphate synthetase superactivity,SOP7,chrX:107628510-107651026,Ribose-phosphate pyrophosphokinase 1
PRPS1,PRPS1 deficiency disorder,SOP7,chrX:107628510-107651026,Ribose-phosphate pyrophosphokinase 1
PRPS1,PRPS1 deficiency disorder,SOP7,chrX:107628510-107651026,Ribose-phosphate pyrophosphokinase 1
BMPR2,congenital heart disease,SOP9,chr2:202376327-202567749,Bone morphogenetic protein receptor type-2
BMPR2,congenital heart disease,SOP9,chr2:202376327-202567749,Bone morphogenetic protein receptor type-2
BMPR2,congenital heart disease,SOP9,chr2:202376327-202567749,Bone morphogenetic protein receptor type-2
BMPR2,congenital heart disease,SOP9,chr2:202376327-202567749,Bone morphogenetic protein receptor type-2
BMPR2,congenital heart disease,SOP9,chr2:202376327-202567749,Bone morphogenetic protein receptor type-2
HBA2,"erythrocytosis, familial, 7",SOP10,chr16:172876-173710,Hemoglobin subunit alpha
HBA2,"erythrocytosis, familial, 7",SOP10,chr16:172876-173710,Hemoglobin subunit alpha
HBA2,"erythrocytosis, familial, 7",SOP10,chr16:172876-173710,Hemoglobin subunit alpha
HBA2,"erythrocytosis, familial, 7",SOP10,chr16:172876-173710,Hemoglobin subunit alpha
HBA2,unstable hemoglobin disease,SOP10,chr16:172876-173710,Hemoglobin subunit alpha
HBA2,unstable hemoglobin disease,SOP10,chr16:172876-173710,Hemoglobin subunit alpha
HBA2,unstable hemoglobin disease,SOP10,chr16:172876-173710,Hemoglobin subunit alpha
HBA2,unstable hemoglobin disease,SOP10,chr16:172876-173710,Hemoglobin subunit alpha
HBA2,"methemoglobinemia, alpha type",SOP9,chr16:172876-173710,Hemoglobin subunit alpha
HBA2,"methemoglobinemia, alpha type",SOP9,chr16:172876-173710,Hemoglobin subunit alpha
HBA2,"methemoglobinemia, alpha type",SOP9,chr16:172876-173710,Hemoglobin subunit alpha
HBA2,"methemoglobinemia, alpha type",SOP9,chr16:172876-173710,Hemoglobin subunit alpha
TCIRG1,dysosteosclerosis,SOP10,chr11:68039025-68053762,V-type proton ATPase 116 kDa subunit a 3
TCIRG1,dysosteosclerosis,SOP10,chr11:68039025-68053762,V-type proton ATPase 116 kDa subunit a 3
TCIRG1,autosomal recessive osteopetrosis 1,SOP9,chr11:68039025-68053762,V-type proton ATPase 116 kDa subunit a 3
TCIRG1,autosomal recessive osteopetrosis 1,SOP9,chr11:68039025-68053762,V-type proton ATPase 116 kDa subunit a 3
PIGW,hyperphosphatasia with intellectual disability syndrome 5,SOP11,chr17:36534987-36539303,Phosphatidylinositol-glycan biosynthesis class W protein
TNNT1,nemaline myopathy,SOP7,chr19:55132698-55149206,Troponin T
TNNT1,nemaline myopathy,SOP7,chr19:55132698-55149206,Troponin T
KARS1,nonsyndromic genetic hearing loss,SOP5,chr16:75627724-75647665,Lysine--tRNA ligase
KARS1,nonsyndromic genetic hearing loss,SOP5,chr16:75627724-75647665,Lysine--tRNA ligase
AKT1,Cowden syndrome 6,SOP11,chr14:104769349-104795748,RAC-alpha serine/threonine-protein kinase
TRIM32,Bardet-Biedl syndrome 11,SOP10,chr9:116687305-116701299,E3 ubiquitin-protein ligase TRIM32
TRIM32,Bardet-Biedl syndrome 11,SOP10,chr9:116687305-116701299,E3 ubiquitin-protein ligase TRIM32
TRIM32,Bardet-Biedl syndrome 11,SOP10,chr9:116687305-116701299,E3 ubiquitin-protein ligase TRIM32
POLD1,non-severe combined immunodeficiency due to polymerase delta deficiency,SOP9,chr19:50384323-50418018,DNA polymerase delta catalytic subunit
POLD1,non-severe combined immunodeficiency due to polymerase delta deficiency,SOP9,chr19:50384323-50418018,DNA polymerase delta catalytic subunit
POLD1,non-severe combined immunodeficiency due to polymerase delta deficiency,SOP9,chr19:50384323-50418018,DNA polymerase delta catalytic subunit
POLD1,non-severe combined immunodeficiency due to polymerase delta deficiency,SOP9,chr19:50384323-50418018,DNA polymerase delta catalytic subunit
POLD1,non-severe combined immunodeficiency due to polymerase delta deficiency,SOP9,chr19:50384323-50418018,DNA polymerase delta catalytic subunit
POLD1,POLD1-related polyposis and colorectal cancer syndrome,SOP9,chr19:50384323-50418018,DNA polymerase delta catalytic subunit
POLD1,POLD1-related polyposis and colorectal cancer syndrome,SOP9,chr19:50384323-50418018,DNA polymerase delta catalytic subunit
POLD1,POLD1-related polyposis and colorectal cancer syndrome,SOP9,chr19:50384323-50418018,DNA polymerase delta catalytic subunit
POLD1,POLD1-related polyposis and colorectal cancer syndrome,SOP9,chr19:50384323-50418018,DNA polymerase delta catalytic subunit
POLD1,POLD1-related polyposis and colorectal cancer syndrome,SOP9,chr19:50384323-50418018,DNA polymerase delta catalytic subunit
EMX2,schizencephaly,SOP11,chr10:117542746-117549546,Homeobox protein EMX2
PDGFRA,congenital heart disease,SOP10,chr4:54229293-54298245,Platelet-derived growth factor receptor alpha
PDGFRA,congenital heart disease,SOP10,chr4:54229293-54298245,Platelet-derived growth factor receptor alpha
AKT3,microcephaly,SOP8,chr1:243488233-243851079,RAC-gamma serine/threonine-protein kinase
AKT3,microcephaly,SOP8,chr1:243488233-243851079,RAC-gamma serine/threonine-protein kinase
ALG6,cystic kidney disease,SOP9,chr1:63367627-63438553,Dolichyl pyrophosphate Man9GlcNAc2 alpha-1
ALG6,cystic kidney disease,SOP9,chr1:63367627-63438553,Dolichyl pyrophosphate Man9GlcNAc2 alpha-1
PCDH15,nonsyndromic genetic hearing loss,SOP6,chr10:53802771-55627942,Protocadherin-15
PCDH15,nonsyndromic genetic hearing loss,SOP6,chr10:53802771-55627942,Protocadherin-15
PCDH15,nonsyndromic genetic hearing loss,SOP6,chr10:53802771-55627942,Protocadherin-15
BIN1,centronuclear myopathy,SOP10,chr2:127048023-127107154,Myc box-dependent-interacting protein 1
BIN1,centronuclear myopathy,SOP10,chr2:127048023-127107154,Myc box-dependent-interacting protein 1
CDKN1B,hereditary nonpolyposis colon cancer,SOP4,chr12:12717368-12722369,Cyclin-dependent kinase inhibitor 1B
CDKN1B,hereditary nonpolyposis colon cancer,SOP4,chr12:12717368-12722369,Cyclin-dependent kinase inhibitor 1B
NEBL,dilated cardiomyopathy,SOP7,chr10:20779973-21293050,Nebulette
CHD1L,congenital anomaly of kidney and urinary tract,SOP4,chr1:147172747-147295762,Chromodomain-helicase-DNA-binding protein 1-like
CASZ1,congenital heart disease,SOP10,chr1:10636604-10796646,Zinc finger protein castor homolog 1
EYA4,dilated cardiomyopathy 1J,SOP7,chr6:133240593-133532128,Protein phosphatase EYA4
EYA4,dilated cardiomyopathy 1J,SOP7,chr6:133240593-133532128,Protein phosphatase EYA4
EYA4,dilated cardiomyopathy 1J,SOP7,chr6:133240593-133532128,Protein phosphatase EYA4
RPS20,Lynch syndrome,SOP10,chr8:56067254-56074506,Small ribosomal subunit protein uS10
COL9A1,Stickler syndrome,SOP5,chr6:70215061-70303084,Collagen alpha-1(IX) chain
COL9A1,Stickler syndrome,SOP5,chr6:70215061-70303084,Collagen alpha-1(IX) chain
CD8A,susceptibility to respiratory infections associated with CD8alpha chain mutation,SOP9,chr2:86784605-86808396,T-cell surface glycoprotein CD8 alpha chain
TJP2,nonsyndromic genetic hearing loss,SOP8,chr9:69121264-69255208,Tight junction protein 2
TJP2,nonsyndromic genetic hearing loss,SOP8,chr9:69121264-69255208,Tight junction protein 2
FAN1,hereditary nonpolyposis colon cancer,SOP4,chr15:30903852-30943108,Fanconi-associated nuclease 1
FAN1,hereditary nonpolyposis colon cancer,SOP4,chr15:30903852-30943108,Fanconi-associated nuclease 1
ESPN,nonsyndromic genetic hearing loss,SOP5,chr1:6424776-6461370,Espin
ESPN,nonsyndromic genetic hearing loss,SOP5,chr1:6424776-6461370,Espin
ESPN,nonsyndromic genetic hearing loss,SOP5,chr1:6424776-6461370,Espin
ESPN,nonsyndromic genetic hearing loss,SOP5,chr1:6424776-6461370,Espin
FBN2,familial thoracic aortic aneurysm and aortic dissection,SOP4,chr5:128257909-128538245,Fibrillin-2
ERMARD,periventricular nodular heterotopia,SOP10,chr6:169751306-169781600,Endoplasmic reticulum membrane-associated RNA degradation protein
FLNA,familial thoracic aortic aneurysm and aortic dissection,SOP4,chrX:154348531-154374634,Filamin-A
FLNA,familial thoracic aortic aneurysm and aortic dissection,SOP4,chrX:154348531-154374634,Filamin-A
FLNA,familial thoracic aortic aneurysm and aortic dissection,SOP4,chrX:154348531-154374634,Filamin-A
GALNT12,"colorectal cancer, susceptibility to, 1",SOP4,chr9:98807670-98850081,Polypeptide N-acetylgalactosaminyltransferase 12
CASP10,autoimmune lymphoproliferative syndrome type 2A,SOP10,chr2:201183141-201229406,Caspase-10
NDUFV2,Leigh syndrome,SOP6,chr18:9102699-9134341,NADH dehydrogenase [ubiquinone] flavoprotein 2
NDUFV2,Leigh syndrome,SOP6,chr18:9102699-9134341,NADH dehydrogenase [ubiquinone] flavoprotein 2
NDUFV2,Leigh syndrome,SOP6,chr18:9102699-9134341,NADH dehydrogenase [ubiquinone] flavoprotein 2
F9,"thrombophilia, X-linked, due to factor 9 defect",SOP9,chrX:139530739-139563459,Coagulation factor IX
F9,"thrombophilia, X-linked, due to factor 9 defect",SOP9,chrX:139530739-139563459,Coagulation factor IX
F9,"thrombophilia, X-linked, due to factor 9 defect",SOP9,chrX:139530739-139563459,Coagulation factor IX
CAPN3,"muscular dystrophy, limb-girdle, autosomal dominant",SOP9,chr15:42359501-42412317,Calpain-3
CAPN3,"muscular dystrophy, limb-girdle, autosomal dominant",SOP9,chr15:42359501-42412317,Calpain-3
CAPN3,"muscular dystrophy, limb-girdle, autosomal dominant",SOP9,chr15:42359501-42412317,Calpain-3
GATAD1,dilated cardiomyopathy,SOP10,chr7:92447482-92495769,GATA zinc finger domain-containing protein 1
GATAD1,dilated cardiomyopathy,SOP10,chr7:92447482-92495769,GATA zinc finger domain-containing protein 1
SLC25A19,Leigh syndrome,SOP7,chr17:75272992-75289433,Mitochondrial thiamine pyrophosphate carrier
SLC25A19,Leigh syndrome,SOP7,chr17:75272992-75289433,Mitochondrial thiamine pyrophosphate carrier
NKX2-5,dilated cardiomyopathy,SOP7,chr5:173232109-173235206,Homeobox protein Nkx-2.5
NKX2-5,dilated cardiomyopathy,SOP7,chr5:173232109-173235206,Homeobox protein Nkx-2.5
MSH3,Lynch syndrome,SOP10,chr5:80654652-80876815,DNA mismatch repair protein Msh3
MSH3,Lynch syndrome,SOP10,chr5:80654652-80876815,DNA mismatch repair protein Msh3
KCNH2,Brugada syndrome,SOP5,chr7:150944961-150978321,Voltage-gated inwardly rectifying potassium channel KCNH2
KCNH2,Brugada syndrome,SOP5,chr7:150944961-150978321,Voltage-gated inwardly rectifying potassium channel KCNH2
KCNH2,Brugada syndrome,SOP5,chr7:150944961-150978321,Voltage-gated inwardly rectifying potassium channel KCNH2
KCNH2,Brugada syndrome,SOP5,chr7:150944961-150978321,Voltage-gated inwardly rectifying potassium channel KCNH2
KCNH2,Brugada syndrome,SOP5,chr7:150944961-150978321,Voltage-gated inwardly rectifying potassium channel KCNH2
TMLHE,autism spectrum disorder,SOP8,chrX:155489011-155612952,Trimethyllysine dioxygenase
FOXP1,congenital heart disease,SOP10,chr3:70954708-71583978,Forkhead box protein P1
FOXP1,congenital heart disease,SOP10,chr3:70954708-71583978,Forkhead box protein P1
ZDHHC15,X-linked complex neurodevelopmental disorder,SOP8,chrX:75368427-75523037,Palmitoyltransferase ZDHHC15
ARHGEF6,non-syndromic X-linked intellectual disability,SOP8,chrX:136665550-136780932,Rho guanine nucleotide exchange factor 6
ZNF41,non-syndromic X-linked intellectual disability,SOP7,chrX:47445178-47483222,Zinc finger protein 41
SHROOM4,X-linked complex neurodevelopmental disorder,SOP8,chrX:50575534-50814194,Protein Shroom4
MAGT1,X-linked intellectual disability,SOP9,chrX:77825747-77895568,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit MAGT1
MAGT1,X-linked intellectual disability,SOP9,chrX:77825747-77895568,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit MAGT1
SLC34A1,Fanconi renotubular syndrome 2,SOP9,chr5:177384434-177398848,Sodium-dependent phosphate transport protein 2A
SLC34A1,Fanconi renotubular syndrome 2,SOP9,chr5:177384434-177398848,Sodium-dependent phosphate transport protein 2A
SLC34A1,"hypercalcemia, infantile, 2",SOP9,chr5:177384434-177398848,Sodium-dependent phosphate transport protein 2A
SLC34A1,"hypercalcemia, infantile, 2",SOP9,chr5:177384434-177398848,Sodium-dependent phosphate transport protein 2A
ZNF674,X-linked intellectual disability,SOP8,chrX:46497725-46545421,Zinc finger protein 674
PKP2,Brugada syndrome 1,SOP5,chr12:32790755-32896777,Plakophilin-2
PKP2,Brugada syndrome 1,SOP5,chr12:32790755-32896777,Plakophilin-2
PKP2,Brugada syndrome 1,SOP5,chr12:32790755-32896777,Plakophilin-2
PKP2,Brugada syndrome 1,SOP5,chr12:32790755-32896777,Plakophilin-2
PKP2,Brugada syndrome 1,SOP5,chr12:32790755-32896777,Plakophilin-2
PKP2,Brugada syndrome 1,SOP5,chr12:32790755-32896777,Plakophilin-2
PKP2,dilated cardiomyopathy,SOP7,chr12:32790755-32896777,Plakophilin-2
PKP2,dilated cardiomyopathy,SOP7,chr12:32790755-32896777,Plakophilin-2
PKP2,dilated cardiomyopathy,SOP7,chr12:32790755-32896777,Plakophilin-2
PKP2,dilated cardiomyopathy,SOP7,chr12:32790755-32896777,Plakophilin-2
PKP2,dilated cardiomyopathy,SOP7,chr12:32790755-32896777,Plakophilin-2
PKP2,dilated cardiomyopathy,SOP7,chr12:32790755-32896777,Plakophilin-2
PKP2,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr12:32790755-32896777,Plakophilin-2
PKP2,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr12:32790755-32896777,Plakophilin-2
PKP2,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr12:32790755-32896777,Plakophilin-2
PKP2,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr12:32790755-32896777,Plakophilin-2
PKP2,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr12:32790755-32896777,Plakophilin-2
PKP2,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr12:32790755-32896777,Plakophilin-2
PKP2,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr12:32790755-32896777,Plakophilin-2
PKP2,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr12:32790755-32896777,Plakophilin-2
PKP2,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr12:32790755-32896777,Plakophilin-2
PKP2,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr12:32790755-32896777,Plakophilin-2
PKP2,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr12:32790755-32896777,Plakophilin-2
PKP2,arrhythmogenic right ventricular cardiomyopathy,SOP7,chr12:32790755-32896777,Plakophilin-2
EN2,complex neurodevelopmental disorder,SOP8,chr7:155458129-155464831,Homeobox protein engrailed-2
ANK2,Brugada syndrome,SOP5,chr4:112705622-113383736,Ankyrin-2
ANK2,Brugada syndrome,SOP5,chr4:112705622-113383736,Ankyrin-2
ANK2,Brugada syndrome,SOP5,chr4:112705622-113383736,Ankyrin-2
ANK2,Brugada syndrome,SOP5,chr4:112705622-113383736,Ankyrin-2
ANK2,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr4:112705622-113383736,Ankyrin-2
ANK2,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr4:112705622-113383736,Ankyrin-2
ANK2,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr4:112705622-113383736,Ankyrin-2
ANK2,catecholaminergic polymorphic ventricular tachycardia,SOP7,chr4:112705622-113383736,Ankyrin-2
ANK2,long QT syndrome,SOP8,chr4:112705622-113383736,Ankyrin-2
ANK2,long QT syndrome,SOP8,chr4:112705622-113383736,Ankyrin-2
ANK2,long QT syndrome,SOP8,chr4:112705622-113383736,Ankyrin-2
ANK2,long QT syndrome,SOP8,chr4:112705622-113383736,Ankyrin-2
KAT6B,RASopathy,SOP6,chr10:74824936-75032624,Histone acetyltransferase KAT6B
KAT6B,RASopathy,SOP6,chr10:74824936-75032624,Histone acetyltransferase KAT6B
KAT6B,RASopathy,SOP6,chr10:74824936-75032624,Histone acetyltransferase KAT6B
KATNAL2,complex neurodevelopmental disorder,SOP7,chr18:46917594-47102243,Katanin p60 ATPase-containing subunit A-like 2
KATNAL2,complex neurodevelopmental disorder,SOP7,chr18:46917594-47102243,Katanin p60 ATPase-containing subunit A-like 2
USH1G,nonsyndromic genetic hearing loss,SOP6,chr17:74916083-74923255,pre-mRNA splicing regulator USH1G
USH1G,nonsyndromic genetic hearing loss,SOP6,chr17:74916083-74923255,pre-mRNA splicing regulator USH1G
USH1G,nonsyndromic genetic hearing loss,SOP6,chr17:74916083-74923255,pre-mRNA splicing regulator USH1G
DPP6,complex neurodevelopmental disorder,SOP8,chr7:153748133-154894285,A-type potassium channel modulatory protein DPP6
DPP6,complex neurodevelopmental disorder,SOP8,chr7:153748133-154894285,A-type potassium channel modulatory protein DPP6
SCN1B,Brugada syndrome 1,SOP5,chr19:35030470-35040449,Sodium channel regulatory subunit beta-1
SCN1B,Brugada syndrome 1,SOP5,chr19:35030470-35040449,Sodium channel regulatory subunit beta-1
SCN1B,Brugada syndrome 1,SOP5,chr19:35030470-35040449,Sodium channel regulatory subunit beta-1
SCN1B,developmental and epileptic encephalopathy,SOP8,chr19:35030470-35040449,Sodium channel regulatory subunit beta-1
SCN1B,developmental and epileptic encephalopathy,SOP8,chr19:35030470-35040449,Sodium channel regulatory subunit beta-1
SCN1B,developmental and epileptic encephalopathy,SOP8,chr19:35030470-35040449,Sodium channel regulatory subunit beta-1
SCN1B,generalized epilepsy with febrile seizures plus,SOP9,chr19:35030470-35040449,Sodium channel regulatory subunit beta-1
SCN1B,generalized epilepsy with febrile seizures plus,SOP9,chr19:35030470-35040449,Sodium channel regulatory subunit beta-1
SCN1B,generalized epilepsy with febrile seizures plus,SOP9,chr19:35030470-35040449,Sodium channel regulatory subunit beta-1
GJA5,congenital heart disease,SOP10,chr1:147756199-147773351,Gap junction alpha-5 protein
SMAD4,pulmonary arterial hypertension,SOP9,chr18:51030213-51085042,Mothers against decapentaplegic homolog 4
SMAD4,pulmonary arterial hypertension,SOP9,chr18:51030213-51085042,Mothers against decapentaplegic homolog 4
SMAD4,pulmonary arterial hypertension,SOP9,chr18:51030213-51085042,Mothers against decapentaplegic homolog 4
SMAD4,pulmonary arterial hypertension,SOP9,chr18:51030213-51085042,Mothers against decapentaplegic homolog 4
SMAD4,pulmonary arterial hypertension,SOP9,chr18:51030213-51085042,Mothers against decapentaplegic homolog 4
SMAD4,Myhre syndrome,SOP8,chr18:51030213-51085042,Mothers against decapentaplegic homolog 4
SMAD4,Myhre syndrome,SOP8,chr18:51030213-51085042,Mothers against decapentaplegic homolog 4
SMAD4,Myhre syndrome,SOP8,chr18:51030213-51085042,Mothers against decapentaplegic homolog 4
SMAD4,Myhre syndrome,SOP8,chr18:51030213-51085042,Mothers against decapentaplegic homolog 4
SMAD4,Myhre syndrome,SOP8,chr18:51030213-51085042,Mothers against decapentaplegic homolog 4
SMAD4,juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome,SOP9,chr18:51030213-51085042,Mothers against decapentaplegic homolog 4
SMAD4,juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome,SOP9,chr18:51030213-51085042,Mothers against decapentaplegic homolog 4
SMAD4,juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome,SOP9,chr18:51030213-51085042,Mothers against decapentaplegic homolog 4
SMAD4,juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome,SOP9,chr18:51030213-51085042,Mothers against decapentaplegic homolog 4
SMAD4,juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome,SOP9,chr18:51030213-51085042,Mothers against decapentaplegic homolog 4
FBN1,Shprintzen-Goldberg syndrome,SOP9,chr15:48408313-48645709,Fibrillin-1
FBN1,Shprintzen-Goldberg syndrome,SOP9,chr15:48408313-48645709,Fibrillin-1
FBN1,Shprintzen-Goldberg syndrome,SOP9,chr15:48408313-48645709,Fibrillin-1
PMS2,hereditary breast carcinoma,SOP9,chr7:5970925-6009106,Mismatch repair endonuclease PMS2
PMS2,hereditary breast carcinoma,SOP9,chr7:5970925-6009106,Mismatch repair endonuclease PMS2
PMS2,hereditary breast carcinoma,SOP9,chr7:5970925-6009106,Mismatch repair endonuclease PMS2
PMS2,hereditary breast carcinoma,SOP9,chr7:5970925-6009106,Mismatch repair endonuclease PMS2
PMS2,hereditary breast carcinoma,SOP9,chr7:5970925-6009106,Mismatch repair endonuclease PMS2
PMS2,hereditary breast carcinoma,SOP9,chr7:5970925-6009106,Mismatch repair endonuclease PMS2
PMS2,hereditary breast carcinoma,SOP9,chr7:5970925-6009106,Mismatch repair endonuclease PMS2
PMS2,Lynch syndrome,SOP9,chr7:5970925-6009106,Mismatch repair endonuclease PMS2
PMS2,Lynch syndrome,SOP9,chr7:5970925-6009106,Mismatch repair endonuclease PMS2
PMS2,Lynch syndrome,SOP9,chr7:5970925-6009106,Mismatch repair endonuclease PMS2
PMS2,Lynch syndrome,SOP9,chr7:5970925-6009106,Mismatch repair endonuclease PMS2
PMS2,Lynch syndrome,SOP9,chr7:5970925-6009106,Mismatch repair endonuclease PMS2
PMS2,Lynch syndrome,SOP9,chr7:5970925-6009106,Mismatch repair endonuclease PMS2
PMS2,Lynch syndrome,SOP9,chr7:5970925-6009106,Mismatch repair endonuclease PMS2
RELN,complex neurodevelopmental disorder,SOP9,chr7:103471789-103989658,Reelin
RELN,complex neurodevelopmental disorder,SOP9,chr7:103471789-103989658,Reelin
RELN,lissencephaly with cerebellar hypoplasia,SOP10,chr7:103471789-103989658,Reelin
RELN,lissencephaly with cerebellar hypoplasia,SOP10,chr7:103471789-103989658,Reelin
HRAS,Noonan syndrome-like disorder with loose anagen hair,SOP5,chr11:532242-535576,GTPase HRas
HRAS,Noonan syndrome-like disorder with loose anagen hair,SOP5,chr11:532242-535576,GTPase HRas
ADGRV1,nonsyndromic genetic hearing loss,SOP6,chr5:90558797-91164437,Adhesion G-protein coupled receptor V1
ADGRV1,nonsyndromic genetic hearing loss,SOP6,chr5:90558797-91164437,Adhesion G-protein coupled receptor V1
AGTR2,X-linked complex neurodevelopmental disorder,SOP7,chrX:116170744-116174974,Type-2 angiotensin II receptor
AGTR2,X-linked complex neurodevelopmental disorder,SOP7,chrX:116170744-116174974,Type-2 angiotensin II receptor
PTPN11,Costello syndrome,SOP5,chr12:112418947-112509918,Tyrosine-protein phosphatase non-receptor type 11
PTPN11,Costello syndrome,SOP5,chr12:112418947-112509918,Tyrosine-protein phosphatase non-receptor type 11
PTPN11,Costello syndrome,SOP5,chr12:112418947-112509918,Tyrosine-protein phosphatase non-receptor type 11
PTPN11,Costello syndrome,SOP5,chr12:112418947-112509918,Tyrosine-protein phosphatase non-receptor type 11
PTPN11,Costello syndrome,SOP5,chr12:112418947-112509918,Tyrosine-protein phosphatase non-receptor type 11
PTPN11,Costello syndrome,SOP5,chr12:112418947-112509918,Tyrosine-protein phosphatase non-receptor type 11
PTPN11,Costello syndrome,SOP5,chr12:112418947-112509918,Tyrosine-protein phosphatase non-receptor type 11
PTPN11,Costello syndrome,SOP5,chr12:112418947-112509918,Tyrosine-protein phosphatase non-receptor type 11
PTPN11,Costello syndrome,SOP5,chr12:112418947-112509918,Tyrosine-protein phosphatase non-receptor type 11
PTPN11,cardiofaciocutaneous syndrome,SOP5,chr12:112418947-112509918,Tyrosine-protein phosphatase non-receptor type 11
PTPN11,cardiofaciocutaneous syndrome,SOP5,chr12:112418947-112509918,Tyrosine-protein phosphatase non-receptor type 11
PTPN11,cardiofaciocutaneous syndrome,SOP5,chr12:112418947-112509918,Tyrosine-protein phosphatase non-receptor type 11
PTPN11,cardiofaciocutaneous syndrome,SOP5,chr12:112418947-112509918,Tyrosine-protein phosphatase non-receptor type 11
PTPN11,cardiofaciocutaneous syndrome,SOP5,chr12:112418947-112509918,Tyrosine-protein phosphatase non-receptor type 11
PTPN11,cardiofaciocutaneous syndrome,SOP5,chr12:112418947-112509918,Tyrosine-protein phosphatase non-receptor type 11
PTPN11,cardiofaciocutaneous syndrome,SOP5,chr12:112418947-112509918,Tyrosine-protein phosphatase non-receptor type 11
PTPN11,cardiofaciocutaneous syndrome,SOP5,chr12:112418947-112509918,Tyrosine-protein phosphatase non-receptor type 11
PTPN11,cardiofaciocutaneous syndrome,SOP5,chr12:112418947-112509918,Tyrosine-protein phosphatase non-receptor type 11
BTK,isolated growth hormone deficiency type III,SOP7,chrX:101349450-101390796,Tyrosine-protein kinase BTK
BTK,isolated growth hormone deficiency type III,SOP7,chrX:101349450-101390796,Tyrosine-protein kinase BTK
TSPEAR,nonsyndromic genetic hearing loss,SOP11,chr21:44497893-44711572,Thrombospondin-type laminin G domain and EAR repeat-containing protein
TSPEAR,nonsyndromic genetic hearing loss,SOP11,chr21:44497893-44711572,Thrombospondin-type laminin G domain and EAR repeat-containing protein
RASA1,Noonan syndrome,SOP5,chr5:87267883-87391916,Ras GTPase-activating protein 1
RASA1,Noonan syndrome,SOP5,chr5:87267883-87391916,Ras GTPase-activating protein 1
SHOC2,Noonan syndrome,SOP5,chr10:110919370-111013665,Leucine-rich repeat protein SHOC-2
SHOC2,Noonan syndrome,SOP5,chr10:110919370-111013665,Leucine-rich repeat protein SHOC-2
SHOC2,Noonan syndrome,SOP5,chr10:110919370-111013665,Leucine-rich repeat protein SHOC-2
SHOC2,Noonan syndrome,SOP5,chr10:110919370-111013665,Leucine-rich repeat protein SHOC-2
SHOC2,Noonan syndrome,SOP5,chr10:110919370-111013665,Leucine-rich repeat protein SHOC-2
SHOC2,Costello syndrome,SOP5,chr10:110919370-111013665,Leucine-rich repeat protein SHOC-2
SHOC2,Costello syndrome,SOP5,chr10:110919370-111013665,Leucine-rich repeat protein SHOC-2
SHOC2,Costello syndrome,SOP5,chr10:110919370-111013665,Leucine-rich repeat protein SHOC-2
SHOC2,Costello syndrome,SOP5,chr10:110919370-111013665,Leucine-rich repeat protein SHOC-2
SHOC2,Costello syndrome,SOP5,chr10:110919370-111013665,Leucine-rich repeat protein SHOC-2
SHOC2,cardiofaciocutaneous syndrome,SOP5,chr10:110919370-111013665,Leucine-rich repeat protein SHOC-2
SHOC2,cardiofaciocutaneous syndrome,SOP5,chr10:110919370-111013665,Leucine-rich repeat protein SHOC-2
SHOC2,cardiofaciocutaneous syndrome,SOP5,chr10:110919370-111013665,Leucine-rich repeat protein SHOC-2
SHOC2,cardiofaciocutaneous syndrome,SOP5,chr10:110919370-111013665,Leucine-rich repeat protein SHOC-2
SHOC2,cardiofaciocutaneous syndrome,SOP5,chr10:110919370-111013665,Leucine-rich repeat protein SHOC-2
SLC6A4,autism spectrum disorder,SOP8,chr17:30194319-30235697,Sodium-dependent serotonin transporter
CNTN6,complex neurodevelopmental disorder,SOP9,chr3:1093024-1404217,Contactin-6
SOS1,Costello syndrome,SOP5,chr2:38981549-39124868,Son of sevenless homolog 1
SOS1,Costello syndrome,SOP5,chr2:38981549-39124868,Son of sevenless homolog 1
SOS1,Costello syndrome,SOP5,chr2:38981549-39124868,Son of sevenless homolog 1
SOS1,Costello syndrome,SOP5,chr2:38981549-39124868,Son of sevenless homolog 1
SOS1,cardiofaciocutaneous syndrome,SOP5,chr2:38981549-39124868,Son of sevenless homolog 1
SOS1,cardiofaciocutaneous syndrome,SOP5,chr2:38981549-39124868,Son of sevenless homolog 1
SOS1,cardiofaciocutaneous syndrome,SOP5,chr2:38981549-39124868,Son of sevenless homolog 1
SOS1,cardiofaciocutaneous syndrome,SOP5,chr2:38981549-39124868,Son of sevenless homolog 1
CDH15,intellectual disability,SOP8,chr16:89171748-89195492,Cadherin-15
CDH15,intellectual disability,SOP8,chr16:89171748-89195492,Cadherin-15
ZNF81,X-linked intellectual disability,SOP8,chrX:47836902-47925627,Zinc finger protein 81
CASR,epilepsy,SOP8,chr3:122183668-122291629,Extracellular calcium-sensing receptor
CASR,epilepsy,SOP8,chr3:122183668-122291629,Extracellular calcium-sensing receptor
CASR,epilepsy,SOP8,chr3:122183668-122291629,Extracellular calcium-sensing receptor
CASR,epilepsy,SOP8,chr3:122183668-122291629,Extracellular calcium-sensing receptor
DSP,hypertrophic cardiomyopathy,SOP9,chr6:7541671-7586714,Desmoplakin
DSP,hypertrophic cardiomyopathy,SOP9,chr6:7541671-7586714,Desmoplakin
DSP,hypertrophic cardiomyopathy,SOP9,chr6:7541671-7586714,Desmoplakin
DSP,hypertrophic cardiomyopathy,SOP9,chr6:7541671-7586714,Desmoplakin
DSP,hypertrophic cardiomyopathy,SOP9,chr6:7541671-7586714,Desmoplakin
DSP,hypertrophic cardiomyopathy,SOP9,chr6:7541671-7586714,Desmoplakin
MSH6,hereditary breast carcinoma,SOP9,chr2:47783145-47810101,DNA mismatch repair protein Msh6
MSH6,hereditary breast carcinoma,SOP9,chr2:47783145-47810101,DNA mismatch repair protein Msh6
MSH6,hereditary breast carcinoma,SOP9,chr2:47783145-47810101,DNA mismatch repair protein Msh6
MSH6,hereditary breast carcinoma,SOP9,chr2:47783145-47810101,DNA mismatch repair protein Msh6
MSH6,hereditary breast carcinoma,SOP9,chr2:47783145-47810101,DNA mismatch repair protein Msh6
MSH6,hereditary breast carcinoma,SOP9,chr2:47783145-47810101,DNA mismatch repair protein Msh6
BMPR1A,pulmonary arterial hypertension,SOP9,chr10:86755763-86932844,Bone morphogenetic protein receptor type-1A
BMPR1A,pulmonary arterial hypertension,SOP9,chr10:86755763-86932844,Bone morphogenetic protein receptor type-1A
BMPR1A,pulmonary arterial hypertension,SOP9,chr10:86755763-86932844,Bone morphogenetic protein receptor type-1A
BARD1,familial ovarian cancer,SOP10,chr2:214725646-214809683,BRCA1-associated RING domain protein 1
BARD1,familial ovarian cancer,SOP10,chr2:214725646-214809683,BRCA1-associated RING domain protein 1
BARD1,familial ovarian cancer,SOP10,chr2:214725646-214809683,BRCA1-associated RING domain protein 1
CNTNAP2,complex neurodevelopmental disorder,SOP8,chr7:146116801-148420998,Contactin-associated protein-like 2
RAB3GAP1,Warburg micro syndrome,SOP7,chr2:135052292-135176396,Rab3 GTPase-activating protein catalytic subunit
RAB3GAP1,Warburg micro syndrome,SOP7,chr2:135052292-135176396,Rab3 GTPase-activating protein catalytic subunit
SOX5,Lamb-Shaffer syndrome,SOP8,chr12:23529504-24562650,Transcription factor SOX-5
RAB3GAP2,Warburg micro syndrome,SOP10,chr1:220148293-220272453,Rab3 GTPase-activating protein non-catalytic subunit
RAB3GAP2,Warburg micro syndrome,SOP10,chr1:220148293-220272453,Rab3 GTPase-activating protein non-catalytic subunit
PRRT2,infantile convulsions and choreoathetosis,SOP7,chr16:29812193-29815881,Proline-rich transmembrane protein 2
PRRT2,infantile convulsions and choreoathetosis,SOP7,chr16:29812193-29815881,Proline-rich transmembrane protein 2
PRSS1,hereditary chronic pancreatitis,SOP7,chr7:142749472-142753072,Serine protease 1
SOX10,Waardenburg syndrome type 4C,SOP6,chr22:37972312-37984555,Transcription factor SOX-10
RAD21,Cornelia de Lange syndrome,SOP7,chr8:116845934-116874776,Double-strand-break repair protein rad21 homolog
PRR12,neuroocular syndrome,SOP10,chr19:49591182-49626439,Proline-rich protein 12
PRODH,hyperprolinemia type 1,SOP7,chr22:18912781-18936553,Proline dehydrogenase 1
PRKN,Parkinson disease,SOP9,chr6:161347417-162727766,E3 ubiquitin-protein ligase parkin
PRKN,Parkinson disease,SOP9,chr6:161347417-162727766,E3 ubiquitin-protein ligase parkin
PRKN,Parkinson disease,SOP9,chr6:161347417-162727766,E3 ubiquitin-protein ligase parkin
PRKAR1A,"Carney complex, type 1",SOP6,chr17:68413623-68551316,cAMP-dependent protein kinase type I-alpha regulatory subunit
PRKAR1A,"Carney complex, type 1",SOP6,chr17:68413623-68551316,cAMP-dependent protein kinase type I-alpha regulatory subunit
RAB28,RAB28-related retinopathy,SOP8,chr4:13367724-13484340,Ras-related protein Rab-28
RAB28,RAB28-related retinopathy,SOP8,chr4:13367724-13484340,Ras-related protein Rab-28
SOX6,complex neurodevelopmental disorder,SOP10,chr11:15966449-16738477,Transcription factor SOX-6
PTCH1,nevoid basal cell carcinoma syndrome,SOP5,chr9:95442980-95516971,Protein patched homolog 1
ST3GAL5,GM3 synthase deficiency,SOP9,chr2:85837120-85889034,Lactosylceramide alpha-2
PYCR1,autosomal recessive cutis laxa type 2B,SOP7,chr17:81932391-81937300,Pyrroline-5-carboxylate reductase 1
SPRED1,Legius syndrome,SOP6,chr15:38252836-38357249,Sprouty-related
SPEN,Radio-Tartaglia syndrome,SOP10,chr1:15847707-15940456,Msx2-interacting protein
SPEN,Radio-Tartaglia syndrome,SOP10,chr1:15847707-15940456,Msx2-interacting protein
SPEG,"myopathy, centronuclear, 5",SOP7,chr2:219434843-219493629,Striated muscle preferentially expressed protein kinase
SRCAP,Floating-Harbor syndrome,SOP9,chr16:30699171-30741409,Helicase SRCAP
PXDN,anterior segment dysgenesis 7,SOP9,chr2:1631887-1744901,Peroxidasin homolog
PURA,complex neurodevelopmental disorder,SOP6,chr5:140114109-140125619,Transcriptional activator protein Pur-alpha
PURA,complex neurodevelopmental disorder,SOP6,chr5:140114109-140125619,Transcriptional activator protein Pur-alpha
PUF60,syndromic intellectual disability,SOP8,chr8:143816344-143829315,Poly(U)-binding-splicing factor PUF60
QRICH1,syndromic intellectual disability,SOP9,chr3:49029707-49094373,Transcriptional regulator QRICH1
SPATA7,inherited retinal dystrophy,SOP10,chr14:88385657-88470350,Spermatogenesis-associated protein 7
SPATA7,inherited retinal dystrophy,SOP10,chr14:88385657-88470350,Spermatogenesis-associated protein 7
STAG1,complex neurodevelopmental disorder,SOP9,chr3:136336236-136752378,Cohesin subunit SA-1
PTEN,PTEN hamartoma tumor syndrome,SOP10,chr10:87863625-87971930,Phosphatidylinositol 3
PTEN,PTEN hamartoma tumor syndrome,SOP10,chr10:87863625-87971930,Phosphatidylinositol 3
PTCHD1,non-syndromic X-linked intellectual disability,SOP5,chrX:23334396-23404374,Patched domain-containing protein 1
PTCHD1,non-syndromic X-linked intellectual disability,SOP5,chrX:23334396-23404374,Patched domain-containing protein 1
QDPR,dihydropteridine reductase deficiency,SOP5,chr4:17486395-17512090,Dihydropteridine reductase
STAT1,immunodeficiency 31B,SOP11,chr2:190969149-191014171,Signal transducer and activator of transcription 1-alpha/beta
STAT1,immunodeficiency 31B,SOP11,chr2:190969149-191014171,Signal transducer and activator of transcription 1-alpha/beta
STAT1,immunodeficiency 31B,SOP11,chr2:190969149-191014171,Signal transducer and activator of transcription 1-alpha/beta
STAT1,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency,SOP11,chr2:190969149-191014171,Signal transducer and activator of transcription 1-alpha/beta
STAT1,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency,SOP11,chr2:190969149-191014171,Signal transducer and activator of transcription 1-alpha/beta
STAT1,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency,SOP11,chr2:190969149-191014171,Signal transducer and activator of transcription 1-alpha/beta
PQBP1,Renpenning syndrome,SOP6,chrX:48897930-48903143,Polyglutamine-binding protein 1
PLCB1,developmental and epileptic encephalopathy,SOP7,chr20:8132266-8884900,1-phosphatidylinositol 4
PLCB1,developmental and epileptic encephalopathy,SOP7,chr20:8132266-8884900,1-phosphatidylinositol 4
PMP22,hereditary neuropathy with liability to pressure palsies,SOP10,chr17:15229779-15265326,Peripheral myelin protein 22
PMP22,hereditary neuropathy with liability to pressure palsies,SOP10,chr17:15229779-15265326,Peripheral myelin protein 22
PMP22,hereditary neuropathy with liability to pressure palsies,SOP10,chr17:15229779-15265326,Peripheral myelin protein 22
PMP22,hereditary neuropathy with liability to pressure palsies,SOP10,chr17:15229779-15265326,Peripheral myelin protein 22
PMP22,Charcot-Marie-Tooth disease type 1A,SOP9,chr17:15229779-15265326,Peripheral myelin protein 22
PMP22,Charcot-Marie-Tooth disease type 1A,SOP9,chr17:15229779-15265326,Peripheral myelin protein 22
PMP22,Charcot-Marie-Tooth disease type 1A,SOP9,chr17:15229779-15265326,Peripheral myelin protein 22
PMP22,Charcot-Marie-Tooth disease type 1A,SOP9,chr17:15229779-15265326,Peripheral myelin protein 22
TARDBP,amyotrophic lateral sclerosis type 10,SOP8,chr1:11012654-11030528,TAR DNA-binding protein 43
TBL1XR1,complex neurodevelopmental disorder,SOP7,chr3:177019344-177201800,F-box-like/WD repeat-containing protein TBL1XR1
TBL1XR1,complex neurodevelopmental disorder,SOP7,chr3:177019344-177201800,F-box-like/WD repeat-containing protein TBL1XR1
PLP1,Pelizeaus-Merzbacher spectrum disorder,SOP5,chrX:103776506-103792619,Myelin proteolipid protein
TBR1,complex neurodevelopmental disorder,SOP7,chr2:161416297-161425870,T-box brain protein 1
PLEKHG5,neuromuscular disease,SOP9,chr1:6467122-6520092,Pleckstrin homology domain-containing family G member 5
PLEKHG5,neuromuscular disease,SOP9,chr1:6467122-6520092,Pleckstrin homology domain-containing family G member 5
PLA2G6,PLA2G6-associated neurodegeneration,SOP10,chr22:38111495-38181830,85/88 kDa calcium-independent phospholipase A2
PLA2G6,PLA2G6-associated neurodegeneration,SOP10,chr22:38111495-38181830,85/88 kDa calcium-independent phospholipase A2
STIL,autosomal recessive primary microcephaly,SOP9,chr1:47250139-47314896,SCL-interrupting locus protein
STIL,autosomal recessive primary microcephaly,SOP9,chr1:47250139-47314896,SCL-interrupting locus protein
TBX4,pulmonary arterial hypertension,SOP8,chr17:61452422-61485110,T-box transcription factor TBX4
TBX4,pulmonary arterial hypertension,SOP8,chr17:61452422-61485110,T-box transcription factor TBX4
TBX5,Holt-Oram syndrome,SOP8,chr12:114353911-114408442,T-box transcription factor TBX5
TCF12,TCF12-related craniosynostosis,SOP8,chr15:56918090-57291310,Transcription factor 12
TCF20,developmental delay with variable intellectual impairment and behavioral abnormalities,SOP7,chr22:42160013-42343537,Transcription factor 20
TCF20,developmental delay with variable intellectual impairment and behavioral abnormalities,SOP7,chr22:42160013-42343537,Transcription factor 20
TCF4,Pitt-Hopkins syndrome,SOP5,chr18:55222185-55635957,Transcription factor 7-like 2
TCF7L2,complex neurodevelopmental disorder,SOP8,chr10:112950247-113167678,Transcription factor 7-like 2
TAOK1,syndromic intellectual disability,SOP8,chr17:29390363-29551903,Serine/threonine-protein kinase TAO1
POGZ,intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome,SOP7,chr1:151402724-151459494,Pogo transposable element with ZNF domain
PRKAG2,PRKAG2-related cardiomyopathy,SOP9,chr7:151556127-151877115,5'-AMP-activated protein kinase subunit gamma-2
PRKAG2,PRKAG2-related cardiomyopathy,SOP9,chr7:151556127-151877115,5'-AMP-activated protein kinase subunit gamma-2
PRKAG2,PRKAG2-related cardiomyopathy,SOP9,chr7:151556127-151877115,5'-AMP-activated protein kinase subunit gamma-2
PRKAG2,PRKAG2-related cardiomyopathy,SOP9,chr7:151556127-151877115,5'-AMP-activated protein kinase subunit gamma-2
STRC,nonsyndromic genetic hearing loss,SOP6,chr15:43599563-43618800,Stereocilin
STRC,nonsyndromic genetic hearing loss,SOP6,chr15:43599563-43618800,Stereocilin
STRC,nonsyndromic genetic hearing loss,SOP6,chr15:43599563-43618800,Stereocilin
STRC,nonsyndromic genetic hearing loss,SOP6,chr15:43599563-43618800,Stereocilin
STX11,familial hemophagocytic lymphohistiocytosis 4,SOP9,chr6:144139963-144191939,Syntaxin-11
PRG4,camptodactyly-arthropathy-coxa vara-pericarditis syndrome,SOP8,chr1:186296273-186314567,Phospholipid phosphatase-related protein type 2
SUMF1,mucosulfatidosis,SOP9,chr3:4034486-4467269,Formylglycine-generating enzyme
SURF1,Leigh syndrome,SOP6,chr9:133351758-133356487,Surfeit locus protein 1
SURF1,Leigh syndrome,SOP6,chr9:133351758-133356487,Surfeit locus protein 1
RAD51D,RAD51D-related cancer predisposition,SOP10,chr17:35092221-35119860,DNA repair protein RAD51 homolog 4
RAD51D,RAD51D-related cancer predisposition,SOP10,chr17:35092221-35119860,DNA repair protein RAD51 homolog 4
RAD51D,RAD51D-related cancer predisposition,SOP10,chr17:35092221-35119860,DNA repair protein RAD51 homolog 4
SYNGAP1,complex neurodevelopmental disorder,SOP6,chr6:33418167-33453689,Ras/Rap GTPase-activating protein SynGAP
PPP2R1A,complex neurodevelopmental disorder,SOP9,chr19:52190052-52229518,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform
PPM1D,syndromic intellectual disability,SOP8,chr17:60600193-60666280,Protein phosphatase 1D
POU4F3,nonsyndromic genetic hearing loss,SOP6,chr5:146338839-146341728,POU domain
POU4F3,nonsyndromic genetic hearing loss,SOP6,chr5:146338839-146341728,POU domain
POU3F3,complex neurodevelopmental disorder,SOP10,chr2:104854115-104858574,POU domain
PORCN,focal dermal hypoplasia,SOP7,chrX:48508992-48520814,Protein-serine O-palmitoleoyltransferase porcupine
POR,Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis,SOP8,chr7:75915155-75986855,NADPH--cytochrome P450 reductase
POLH,xeroderma pigmentosum variant type,SOP6,chr6:43576185-43620523,DNA polymerase eta
POLE,POLE-related polyposis and colorectal cancer syndrome,SOP9,chr12:132623762-132687342,DNA polymerase epsilon catalytic subunit A
POLE,POLE-related polyposis and colorectal cancer syndrome,SOP9,chr12:132623762-132687342,DNA polymerase epsilon catalytic subunit A
POLE,POLE-related polyposis and colorectal cancer syndrome,SOP9,chr12:132623762-132687342,DNA polymerase epsilon catalytic subunit A
SMS,syndromic X-linked intellectual disability Snyder type,SOP5,chrX:21940709-21994837,Spermine synthase
SIL1,Marinesco-Sjogren syndrome,SOP10,chr5:138946724-139198368,Nucleotide exchange factor SIL1
SIN3A,SIN3A-related intellectual disability syndrome,SOP9,chr15:75369379-75455815,Paired amphipathic helix protein Sin3a
SIN3A,SIN3A-related intellectual disability syndrome,SOP9,chr15:75369379-75455815,Paired amphipathic helix protein Sin3a
SCN2A,complex neurodevelopmental disorder,SOP6,chr2:165239414-165392304,Sodium channel protein type 2 subunit alpha
SIX1,branchio-oto-renal syndrome,SOP6,chr14:60643421-60649477,Homeobox protein SIX1
SKIC3,trichohepatoenteric syndrome 1,SOP10,chr5:95463894-95554977,Superkiller complex protein 3
SCARB2,progressive myoclonus epilepsy,SOP7,chr4:76158737-76234532,Lysosome membrane protein 2
SHANK3,Phelan-McDermid syndrome,SOP6,chr22:50672823-50733212,SH3 and multiple ankyrin repeat domains protein 3
SBF2,Charcot-Marie-Tooth disease type 4B2,SOP8,chr11:9778668-10303837,Myotubularin-related protein 13
SATB2,SATB2 associated disorder,SOP7,chr2:199269500-199471266,DNA-binding protein SATB2
RYR1,RYR1-related myopathy,SOP7,chr19:38433691-38587564,Ryanodine receptor 1
RYR1,RYR1-related myopathy,SOP7,chr19:38433691-38587564,Ryanodine receptor 1
RYR1,RYR1-related myopathy,SOP7,chr19:38433691-38587564,Ryanodine receptor 1
RYR1,RYR1-related myopathy,SOP7,chr19:38433691-38587564,Ryanodine receptor 1
RYR1,RYR1-related myopathy,SOP7,chr19:38433691-38587564,Ryanodine receptor 1
RYR1,RYR1-related myopathy,SOP7,chr19:38433691-38587564,Ryanodine receptor 1
RYR1,"malignant hyperthermia, susceptibility to, 1",SOP8,chr19:38433691-38587564,Ryanodine receptor 1
RYR1,"malignant hyperthermia, susceptibility to, 1",SOP8,chr19:38433691-38587564,Ryanodine receptor 1
RYR1,"malignant hyperthermia, susceptibility to, 1",SOP8,chr19:38433691-38587564,Ryanodine receptor 1
SLC16A2,Allan-Herndon-Dudley syndrome,SOP5,chrX:74421493-74533916,Monocarboxylate transporter 8
SLC17A5,free sialic acid storage disease,SOP10,chr6:73593379-73653992,Sialin
RUNX1,hereditary thrombocytopenia and hematologic cancer predisposition syndrome,SOP5,chr21:34787801-35049302,Runt-related transcription factor 1
RUNX1,hereditary thrombocytopenia and hematologic cancer predisposition syndrome,SOP5,chr21:34787801-35049302,Runt-related transcription factor 1
RUNX1,hereditary thrombocytopenia and hematologic cancer predisposition syndrome,SOP5,chr21:34787801-35049302,Runt-related transcription factor 1
SHANK2,complex neurodevelopmental disorder,SOP6,chr11:70467854-71253228,SH3 and multiple ankyrin repeat domains protein 2
RAG1,recombinase activating gene 1 deficiency,SOP8,chr11:36510353-36579762,V(D)J recombination-activating protein 1
SDHB,mitochondrial disease,SOP8,chr1:17018722-17054032,Succinate dehydrogenase [ubiquinone] iron-sulfur subunit
SDHB,mitochondrial disease,SOP8,chr1:17018722-17054032,Succinate dehydrogenase [ubiquinone] iron-sulfur subunit
SDHB,mitochondrial disease,SOP8,chr1:17018722-17054032,Succinate dehydrogenase [ubiquinone] iron-sulfur subunit
SDHB,mitochondrial disease,SOP8,chr1:17018722-17054032,Succinate dehydrogenase [ubiquinone] iron-sulfur subunit
SDHB,mitochondrial disease,SOP8,chr1:17018722-17054032,Succinate dehydrogenase [ubiquinone] iron-sulfur subunit
SDHB,hereditary pheochromocytoma-paraganglioma,SOP8,chr1:17018722-17054032,Succinate dehydrogenase [ubiquinone] iron-sulfur subunit
SDHB,hereditary pheochromocytoma-paraganglioma,SOP8,chr1:17018722-17054032,Succinate dehydrogenase [ubiquinone] iron-sulfur subunit
SDHB,hereditary pheochromocytoma-paraganglioma,SOP8,chr1:17018722-17054032,Succinate dehydrogenase [ubiquinone] iron-sulfur subunit
SDHB,hereditary pheochromocytoma-paraganglioma,SOP8,chr1:17018722-17054032,Succinate dehydrogenase [ubiquinone] iron-sulfur subunit
SDHB,hereditary pheochromocytoma-paraganglioma,SOP8,chr1:17018722-17054032,Succinate dehydrogenase [ubiquinone] iron-sulfur subunit
SEC23B,congenital dyserythropoietic anemia type 2,SOP11,chr20:18507548-18561415,Protein transport protein Sec23B
SERAC1,Leigh syndrome,SOP7,chr6:158109519-158168262,Protein SERAC1
SERAC1,Leigh syndrome,SOP7,chr6:158109519-158168262,Protein SERAC1
SET,intellectual disability,SOP8,chr9:128683424-128696396,Protein SET
SETBP1,complex neurodevelopmental disorder,SOP7,chr18:44680073-45068510,SET-binding protein
SETBP1,complex neurodevelopmental disorder,SOP7,chr18:44680073-45068510,SET-binding protein
SETBP1,complex neurodevelopmental disorder,SOP7,chr18:44680073-45068510,SET-binding protein
SETBP1,Schinzel-Giedion syndrome,SOP8,chr18:44680073-45068510,SET-binding protein
SETBP1,Schinzel-Giedion syndrome,SOP8,chr18:44680073-45068510,SET-binding protein
SETBP1,Schinzel-Giedion syndrome,SOP8,chr18:44680073-45068510,SET-binding protein
SETD1B,complex neurodevelopmental disorder,SOP11,chr12:121790155-121832656,Histone-lysine N-methyltransferase SETD1B
SDHAF2,hereditary pheochromocytoma-paraganglioma,SOP8,chr11:61430124-61446733,Succinate dehydrogenase assembly factor 2
SDHAF2,hereditary pheochromocytoma-paraganglioma,SOP8,chr11:61430124-61446733,Succinate dehydrogenase assembly factor 2
SDHAF2,hereditary pheochromocytoma-paraganglioma,SOP8,chr11:61430124-61446733,Succinate dehydrogenase assembly factor 2
SHANK1,complex neurodevelopmental disorder,SOP10,chr19:50659255-50719802,SH3 and multiple ankyrin repeat domains protein 1
SDCCAG8,Bardet-Biedl syndrome 16,SOP11,chr1:243256041-243500091,Serologically defined colon cancer antigen 8
SCN8A,complex neurodevelopmental disorder,SOP5,chr12:51591233-51812864,Sodium channel protein type 8 subunit alpha
SETD5,syndromic complex neurodevelopmental disorder,SOP9,chr3:9397615-9478154,Histone-lysine N-methyltransferase SETD5
SETD5,syndromic complex neurodevelopmental disorder,SOP9,chr3:9397615-9478154,Histone-lysine N-methyltransferase SETD5
SF3B4,SF3B4-related acrofacial dysostosis,SOP9,chr1:149923317-149927803,Splicing factor 3B subunit 4
SF3B4,SF3B4-related acrofacial dysostosis,SOP9,chr1:149923317-149927803,Splicing factor 3B subunit 4
SGSH,mucopolysaccharidosis type 3A,SOP9,chr17:80200673-80220333,N-sulphoglucosamine sulphohydrolase
SH3TC2,obsolete autosomal recessive hereditary demyelinating motor and sensory neuropathy,SOP8,chr5:148982150-149063062,SH3 domain and tetratricopeptide repeat-containing protein 2
SH3TC2,obsolete autosomal recessive hereditary demyelinating motor and sensory neuropathy,SOP8,chr5:148982150-149063062,SH3 domain and tetratricopeptide repeat-containing protein 2
RTTN,microcephalic primordial dwarfism due to RTTN deficiency,SOP11,chr18:70003031-70205687,Rotatin
RTTN,microcephalic primordial dwarfism due to RTTN deficiency,SOP11,chr18:70003031-70205687,Rotatin
RSPH4A,primary ciliary dyskinesia 11,SOP8,chr6:116616479-116632985,Radial spoke head protein 4 homolog A
SLC24A1,inherited retinal dystrophy,SOP10,chr15:65611350-65661002,Sodium/potassium/calcium exchanger 1
SLC24A1,inherited retinal dystrophy,SOP10,chr15:65611350-65661002,Sodium/potassium/calcium exchanger 1
RARS2,mitochondrial disease,SOP8,chr6:87513938-87589987,Probable arginine--tRNA ligase
RARS2,mitochondrial disease,SOP8,chr6:87513938-87589987,Probable arginine--tRNA ligase
SLC38A8,foveal hypoplasia - optic nerve decussation defect - anterior segment dysgenesis syndrome,SOP9,chr16:84009667-84043372,Solute carrier family 38 member 8
SLC6A3,SLC6A3-related dopamine transporter deficiency syndrome,SOP9,chr5:1392794-1445440,Sodium-dependent dopamine transporter
SLC6A3,SLC6A3-related dopamine transporter deficiency syndrome,SOP9,chr5:1392794-1445440,Sodium-dependent dopamine transporter
RET,multiple endocrine neoplasia type 2B,SOP7,chr10:43077069-43130351,Proto-oncogene tyrosine-protein kinase receptor Ret
RET,multiple endocrine neoplasia type 2B,SOP7,chr10:43077069-43130351,Proto-oncogene tyrosine-protein kinase receptor Ret
RET,multiple endocrine neoplasia type 2B,SOP7,chr10:43077069-43130351,Proto-oncogene tyrosine-protein kinase receptor Ret
RET,multiple endocrine neoplasia type 2B,SOP7,chr10:43077069-43130351,Proto-oncogene tyrosine-protein kinase receptor Ret
RET,multiple endocrine neoplasia type 2A,SOP7,chr10:43077069-43130351,Proto-oncogene tyrosine-protein kinase receptor Ret
RET,multiple endocrine neoplasia type 2A,SOP7,chr10:43077069-43130351,Proto-oncogene tyrosine-protein kinase receptor Ret
RET,multiple endocrine neoplasia type 2A,SOP7,chr10:43077069-43130351,Proto-oncogene tyrosine-protein kinase receptor Ret
RET,multiple endocrine neoplasia type 2A,SOP7,chr10:43077069-43130351,Proto-oncogene tyrosine-protein kinase receptor Ret
SLC7A7,lysinuric protein intolerance,SOP7,chr14:22773222-22819791,Y+L amino acid transporter 1
SLC9A6,Christianson syndrome,SOP5,chrX:135973837-136047269,Sodium/hydrogen exchanger 6
SMAD2,congenital heart disease,SOP9,chr18:47808957-47930872,Mothers against decapentaplegic homolog 2
RDX,nonsyndromic genetic hearing loss,SOP6,chr11:110174922-110296614,Radixin
RDX,nonsyndromic genetic hearing loss,SOP6,chr11:110174922-110296614,Radixin
RDX,nonsyndromic genetic hearing loss,SOP6,chr11:110174922-110296614,Radixin
RDX,nonsyndromic genetic hearing loss,SOP6,chr11:110174922-110296614,Radixin
RB1,retinoblastoma,SOP7,chr13:48303751-48481890,Retinoblastoma-associated protein
RB1,retinoblastoma,SOP7,chr13:48303751-48481890,Retinoblastoma-associated protein
RAI1,Smith-Magenis syndrome,SOP5,chr17:17681458-17811453,Retinoic acid-induced protein 1
RSPH1,primary ciliary dyskinesia 24,SOP8,chr21:42472486-42496224,Radial spoke head 1 homolog
SMARCA2,intellectual disability-sparse hair-brachydactyly syndrome,SOP7,chr9:2015347-2193624,Probable global transcription activator SNF2L2
SMARCB1,rhabdoid tumor predisposition syndrome 1,SOP6,chr22:23786966-23838009,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1
SMARCB1,rhabdoid tumor predisposition syndrome 1,SOP6,chr22:23786966-23838009,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1
SMARCB1,rhabdoid tumor predisposition syndrome 1,SOP6,chr22:23786966-23838009,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1
SMARCE1,familial meningioma,SOP7,chr17:40624962-40647818,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1
RAG2,recombinase activating gene 2 deficiency,SOP8,chr11:36590996-36598236,V(D)J recombination-activating protein 2
RAG2,recombinase activating gene 2 deficiency,SOP8,chr11:36590996-36598236,V(D)J recombination-activating protein 2
SLC35A2,X-linked complex neurodevelopmental disorder,SOP8,chrX:48903183-48911958,UDP-galactose translocator
SLC35A2,X-linked complex neurodevelopmental disorder,SOP8,chrX:48903183-48911958,UDP-galactose translocator
RETREG1,hereditary sensory and autonomic neuropathy,SOP10,chr5:16473053-16616997,Reticulophagy regulator 1
RETREG1,hereditary sensory and autonomic neuropathy,SOP10,chr5:16473053-16616997,Reticulophagy regulator 1
RFX6,monogenic diabetes,SOP10,chr6:116877242-116932161,DNA-binding protein RFX6
RFX6,monogenic diabetes,SOP10,chr6:116877242-116932161,DNA-binding protein RFX6
RS1,X-linked retinoschisis,SOP8,chrX:18639688-18672108,Retinoschisin
RPS6KA3,Coffin-Lowry syndrome,SOP6,chrX:20149911-20267097,Ribosomal protein S6 kinase alpha-3
SLC25A1,mitochondrial disease,SOP10,chr22:19175581-19178736,Tricarboxylate transport protein
SLC25A1,mitochondrial disease,SOP10,chr22:19175581-19178736,Tricarboxylate transport protein
RPS19,Diamond-Blackfan anemia,SOP9,chr19:41860255-41872925,Small ribosomal subunit protein eS19
RPS19,Diamond-Blackfan anemia,SOP9,chr19:41860255-41872925,Small ribosomal subunit protein eS19
RP2,RP2-related retinopathy,SOP8,chrX:46837043-46882358,Protein XRP2
RP2,RP2-related retinopathy,SOP8,chrX:46837043-46882358,Protein XRP2
ROGDI,amelocerebrohypohidrotic syndrome,SOP9,chr16:4796968-4802633,Protein rogdi homolog
ROBO3,"gaze palsy, familial horizontal, with progressive scoliosis 1",SOP9,chr11:124865432-124881471,Roundabout homolog 3
RNF168,RIDDLE syndrome,SOP9,chr3:196468783-196503768,E3 ubiquitin-protein ligase RNF168
RNASEH2A,RNASEH2A-related type 1 interferonopathy,SOP10,chr19:12806584-12813640,Ribonuclease H2 subunit A
RNASEH2A,RNASEH2A-related type 1 interferonopathy,SOP10,chr19:12806584-12813640,Ribonuclease H2 subunit A
SLC25A13,citrin deficiency,SOP7,chr7:96120220-96322098,Electrogenic aspartate/glutamate antiporter SLC25A13
SLC25A13,citrin deficiency,SOP7,chr7:96120220-96322098,Electrogenic aspartate/glutamate antiporter SLC25A13
SLC25A13,citrin deficiency,SOP7,chr7:96120220-96322098,Electrogenic aspartate/glutamate antiporter SLC25A13
SLC25A13,citrin deficiency,SOP7,chr7:96120220-96322098,Electrogenic aspartate/glutamate antiporter SLC25A13
SLC25A13,citrin deficiency,SOP7,chr7:96120220-96322098,Electrogenic aspartate/glutamate antiporter SLC25A13
RMRP,cartilage-hair hypoplasia,SOP8,chr9:35657750-35658019,No Protein Found
RMND1,mitochondrial disease,SOP9,chr6:151404762-151452126,Required for meiotic nuclear division protein 1 homolog
RMND1,mitochondrial disease,SOP9,chr6:151404762-151452126,Required for meiotic nuclear division protein 1 homolog
SLC2A1,GLUT1 deficiency syndrome,SOP6,chr1:42925353-42958868,Solute carrier family 2
SLC2A1,GLUT1 deficiency syndrome,SOP6,chr1:42925353-42958868,Solute carrier family 2
SLC2A10,arterial tortuosity syndrome,SOP11,chr20:46708320-46736347,Solute carrier family 2
RIN2,RIN2 syndrome,SOP9,chr20:19757599-20002456,Ras and Rab interactor 2
TCOF1,Treacher-Collins syndrome,SOP6,chr5:150357697-150400293,Treacle protein
TCOF1,Treacher-Collins syndrome,SOP6,chr5:150357697-150400293,Treacle protein
NEXMIF,X-linked complex neurodevelopmental disorder,SOP7,chrX:74732856-74925452,Neurite extension and migration factor
NEXMIF,X-linked complex neurodevelopmental disorder,SOP7,chrX:74732856-74925452,Neurite extension and migration factor
TCTN2,Joubert syndrome 24,SOP9,chr12:123671113-123708399,Tectonic-2
TCTN2,Joubert syndrome 24,SOP9,chr12:123671113-123708399,Tectonic-2
HNF1B,renal cysts and diabetes syndrome,SOP8,chr17:37686431-37745059,Hepatocyte nuclear factor 1-beta
UPF3B,X-linked complex neurodevelopmental disorder,SOP6,chrX:119805311-119852963,Regulator of nonsense transcripts 3B
UPF3B,X-linked complex neurodevelopmental disorder,SOP6,chrX:119805311-119852963,Regulator of nonsense transcripts 3B
WDR45,X-linked complex neurodevelopmental disorder,SOP7,chrX:49074442-49101178,WD repeat domain phosphoinositide-interacting protein 4
WDR45,X-linked complex neurodevelopmental disorder,SOP7,chrX:49074442-49101178,WD repeat domain phosphoinositide-interacting protein 4
ZNF292,complex neurodevelopmental disorder,SOP7,chr6:87155565-87265943,Zinc finger protein 292
ZNF711,X-linked complex neurodevelopmental disorder,SOP9,chrX:85243991-85273357,Zinc finger protein 711
ZNF711,X-linked complex neurodevelopmental disorder,SOP9,chrX:85243991-85273357,Zinc finger protein 711
AHCY,hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase,SOP11,chr20:34231981-34311836,Adenosylhomocysteinase
AICDA,hyper-IgM syndrome type 2,SOP10,chr12:8602170-8612859,Single-stranded DNA cytosine deaminase
AICDA,hyper-IgM syndrome type 2,SOP10,chr12:8602170-8612859,Single-stranded DNA cytosine deaminase
ARHGEF9,X-linked complex neurodevelopmental disorder,SOP10,chrX:63634967-63785214,Rho guanine nucleotide exchange factor 9
ARSL,X-linked chondrodysplasia punctata 1,SOP10,chrX:2934521-2968245,Arylsulfatase L
B4GALT7,"Ehlers-Danlos syndrome, spondylodysplastic type, 1",SOP10,chr5:177600132-177610330,Beta-1
BBS12,BBS12-related ciliopathy,SOP10,chr4:122700442-122744939,Chaperonin-containing T-complex member BBS12
BBS12,BBS12-related ciliopathy,SOP10,chr4:122700442-122744939,Chaperonin-containing T-complex member BBS12
BBS5,BBS5-related ciliopathy,SOP10,chr2:169479494-169506655,BBSome complex member BBS5
BBS5,BBS5-related ciliopathy,SOP10,chr2:169479494-169506655,BBSome complex member BBS5
BBS7,BBS7-related ciliopathy,SOP9,chr4:121824329-121870474,BBSome complex member BBS7
BBS7,BBS7-related ciliopathy,SOP9,chr4:121824329-121870474,BBSome complex member BBS7
